0001493152-21-028645.txt : 20211115 0001493152-21-028645.hdr.sgml : 20211115 20211115163143 ACCESSION NUMBER: 0001493152-21-028645 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: My Size, Inc. CENTRAL INDEX KEY: 0001211805 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37370 FILM NUMBER: 211411357 BUSINESS ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 BUSINESS PHONE: 972-36009030 MAIL ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 FORMER COMPANY: FORMER CONFORMED NAME: Mysize Inc. DATE OF NAME CHANGE: 20150317 FORMER COMPANY: FORMER CONFORMED NAME: TOPSPIN MEDICAL INC DATE OF NAME CHANGE: 20021226 10-Q 1 form10-q.htm
0001211805 false --12-31 Q3 5 0001211805 2021-01-01 2021-09-30 0001211805 2021-11-10 0001211805 2021-09-30 0001211805 2020-12-31 0001211805 2020-01-01 2020-09-30 0001211805 2021-07-01 2021-09-30 0001211805 2020-07-01 2020-09-30 0001211805 us-gaap:CommonStockMember 2020-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001211805 us-gaap:RetainedEarningsMember 2020-12-31 0001211805 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001211805 2021-01-01 2021-06-30 0001211805 us-gaap:CommonStockMember 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-09-30 0001211805 us-gaap:CommonStockMember 2019-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001211805 us-gaap:RetainedEarningsMember 2019-12-31 0001211805 2019-12-31 0001211805 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001211805 2020-01-01 2020-06-30 0001211805 us-gaap:CommonStockMember 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-09-30 0001211805 2020-09-30 0001211805 us-gaap:CommonStockMember 2021-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001211805 us-gaap:RetainedEarningsMember 2021-06-30 0001211805 2021-06-30 0001211805 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001211805 us-gaap:CommonStockMember 2020-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001211805 us-gaap:RetainedEarningsMember 2020-06-30 0001211805 2020-06-30 0001211805 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001211805 us-gaap:PrivatePlacementMember MYSZ:ShoshanaZigdonMember 2021-05-25 2021-05-26 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001211805 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001211805 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantMember MYSZ:WarrantOneMember 2021-05-31 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantOneMember 2021-05-31 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantTwoMember 2021-05-31 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantMember MYSZ:WarrantOneMember 2021-06-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantOneMember 2021-06-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantTwoMember 2021-06-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantOneMember 2021-01-01 2021-09-30 0001211805 MYSZ:ConsultingAgreementMember MYSZ:ConsultantOneMember MYSZ:WarrantOneMember 2021-07-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2017-03-01 2017-03-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2020-08-10 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-24 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember srt:MinimumMember 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember srt:MaximumMember 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2020-08-09 0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2020-08-09 0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2020-08-10 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2021-01-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2021-07-01 2021-09-30 0001211805 MYSZ:NorthEmpireLLCMember MYSZ:SecuritiesPurchaseAgreementMember 2018-08-06 2018-08-07 0001211805 MYSZ:NorthEmpireLLCMember 2018-08-01 2018-08-02 0001211805 MYSZ:NorthEmpireLLCMember 2018-09-26 2018-09-27 0001211805 MYSZ:FidelityVentureCapitalLtdMember MYSZ:MrDrorAtzmonMember 2021-07-04 2021-07-05 0001211805 MYSZ:FidelityVentureCapitalLtdMember MYSZ:MrDrorAtzmonMember 2021-07-05 0001211805 MYSZ:FidelityVentureCapitalLtdMember 2021-07-04 2021-07-05 0001211805 us-gaap:IPOMember 2021-01-07 2021-01-08 0001211805 2021-01-31 0001211805 2021-02-28 0001211805 2021-01-01 2021-01-31 0001211805 2021-01-01 2021-02-28 0001211805 us-gaap:IPOMember 2021-03-24 2021-03-25 0001211805 us-gaap:OverAllotmentOptionMember 2021-05-06 2021-05-07 0001211805 us-gaap:IPOMember 2021-05-07 0001211805 us-gaap:IPOMember 2021-05-06 2021-05-07 0001211805 us-gaap:SubsequentEventMember MYSZ:HoldersMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:WarrantMember 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember MYSZ:WarrantOneMember 2021-10-26 0001211805 us-gaap:SubsequentEventMember 2021-10-28 0001211805 us-gaap:SubsequentEventMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-28 0001211805 us-gaap:SubsequentEventMember MYSZ:SettlementAgreementMember 2021-11-03 2021-11-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:ILS

 

 

 

U. S. Securities and Exchange Commission

Washington, D. C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File No. 001-37370

 

MY SIZE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   51-0394637

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

I.D. No.)

 

HaYarden 4, POB 1026, Airport City, Israel, 7010000

(Address of principal executive offices)

 

+972-3-600-9030

Registrant’s telephone number, including area code:

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   MYSZ   Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: as of November 10, 2021, 23,982,503 shares of common stock, par value $0.001 per share were issued and outstanding.

 

 

 

 
 

 

MY SIZE, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2021

 

TABLE OF CONTENTS

 

    PAGE
PART I - FINANCIAL INFORMATION 1
     
Item 1. Condensed Consolidated Interim Financial Statements (Unaudited) 1
  Condensed Consolidated Interim Balance Sheets 3
  Condensed Consolidated Interim Statements of Comprehensive Loss 4
  Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity 5
  Condensed Consolidated Interim Statements of Cash Flows 6
  Notes to Condensed Consolidated Interim Financial Statements 7-11
Item 2. Management’s Discussion & Analysis of Financial Condition and Results of Operations 12-17
Item 3. Quantitative and Qualitative Disclosure About Market Risk 18
Item 4. Controls and Procedures 18
     
PART II - OTHER INFORMATION 19
     
Item 1. Legal Proceedings 19
Item 1A. Risk Factors 19
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
Item 3. Defaults Upon Senior Securities 19
Item 4. Mine Safety Disclosures 19
Item 5 Other information 19
Item 6. Exhibits 20

 

i 
 

 

PART I

FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

My Size Inc. and Subsidiaries

 

Condensed Consolidated

Interim

Financial Statements

As of September 30, 2021

(unaudited)

U.S. Dollars in Thousands

 

1
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Financial Statements as of September 30, 2021 (Unaudited)

Contents

 

  Page
   
Condensed Consolidated Interim Balance Sheets (Unaudited) 3
   
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) 4
   
Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited) 5
   
Condensed Consolidated Interim Statements of Cash flows (Unaudited) 6
   
Notes to Condensed Consolidated Interim Financial Statements (Unaudited) 7-11

 

2
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Balance Sheets (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

   September 30,  December 31,
   2021  2020
Assets          
Current Assets:          
Cash and cash equivalents   3,539    1,689 
Restricted cash   270    85 
Restricted deposit   -    184 
Accounts receivable   37    28 
Other receivables and prepaid expenses   121    482 
Total current assets   3,967    2,468 
           
Property and equipment, net   108    128 
Right-of-use asset   792    911 
Investment in marketable securities   105    59 
Total non-current assets   1,005    1,098 
           
Total assets   4,972    3,566 
           
Liabilities and stockholders’ equity          
           
Current liabilities:          
Operating lease liability   130    129 
Trade payables   556    381 
Accounts payable   705    400 
Derivatives  -  1 
Total current liabilities   1,391    911 
           
Operating lease liability   493    579 
Total non-current liabilities   493    579 
           
Total liabilities   1,884    1,490 
           
COMMITMENTS AND CONTINGENCIES   -      
           
Stockholders’ equity:          
Stock Capital -          
Common stock of $0.001 par value - Authorized: 100,000,000 shares; Issued and outstanding: 15,069,587 and 7,232,836 as of September 30, 2021 and December 31, 2020, respectively   15    7 
Additional paid-in capital   45,981    37,164 
Accumulated other comprehensive loss   (432)   (424)
Accumulated deficit   (42,476)   (34,671)
Total stockholders’ equity   3,088    2,076 
Total liabilities and stockholders’ equity   4,972    3,566 

 

(*) Represents an amount less than $1

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

3
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

             
  

Nine-Months Ended

September 30,

 

Three-Months Ended

September 30,

   2021  2020  2021  2020
             
Revenues   88    139    31    88 
Cost of revenues   -    (2)   -    (1)
Gross profit   88    137    31    87 
                     
Operating expenses                    
Research and development   (3,842)   (1,085)   (462)   (397)
Sales and marketing   (1,798)   (1,632)   (521)   (555)
General and administrative   (2,303)   (1,855)   (1,074)   (777)
                     
Total operating expenses   (7,943)   (4,572)   (2,507)   (1,729)
Operating loss   (7,855)   (4,435)   (2,026)   (1,642)
Financial income (expenses), net   50    (2)   18    (32)
Net loss   (7,805)   (4,437)   (2,008)   (1,674)
                     
Other comprehensive income (loss):                    
                     
Foreign currency translation differences   (8)   53    8    50 
                     
Total comprehensive loss   (7,813)   (4,384)   (2,000)   (1,624)
                     
Basic and diluted loss per share   (0.62)   (0.89)   (0.13)   (0.23)
Basic and diluted weighted average number of shares outstanding   12,546,022    4,971,202    15,044,184    7,217,619 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements

 

4
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

                         
   Common stock   Additional paid-in   Accumulated other comprehensive   Accumulated   Total stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of January 1, 2021   7,232,836    7    37,164    (424)   (34,671)   2,076 
                               
Stock-based compensation related to options granted to employees and consultants   -    -    350    -    -    350 
Exercise of options granted to employees   4,458    

**

    

**

    -    -    

**

 
Restricted shares issued to shareholder (*)   2,500,000    3    2,615    -    -    2,618 
Issuance of shares, net of issuance cost of $768   4,580,491    4    5,031    -    -    5,035 
Exercise of warrants   751,802    1    821    -    -    822 
Total comprehensive loss   -    -    -    (8)   (7,805)   (7,813)
Balance as of September 30, 2021   15,069,587    15    45,981    (432)   (42,476)   3,088 

 

(*) See note 1 c.
(**) Represents an amount less than $1

 

   Common stock   Additional paid-in   Accumulated other comprehensive   Accumulated   Total stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of January 1, 2020   2,085,900    2    30,102    (539)   (28,514)   1,051 
Stock-based compensation related to options granted to employees and consultants   -    -    388    -    -    388 
Issuance of shares, net of issuance cost of $1,000   2,439,802    3    5,992    -    -    5,995 
Exercise of warrants and pre funded warrants   2,707,134    2    97              99 
Liability reclassified to equity   -    -    328    -    -    328 
Total comprehensive loss   -    -    -    53    (4,437)   (4,384)
Balance as of September 30, 2020   7,232,836    7    36,907    (486)   (32,951)   3,477 

 

   Common stock   Additional paid-in   Accumulated other comprehensive   Accumulated   Total stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of July 1, 2021   15,038,327    15    45,838    (440)   (40,468)   4,945 
                               
Stock-based compensation related to options granted to employees and consultants   -    -    118    -    -    118 
Exercise of options granted to employees   4,458   -

**

   -

**

    -    -   -

**

 
Exercise of warrants   26,802   - **    25    -    -    25 
Total comprehensive loss   -    -    -    8    (2,008)   (2,000)
Balance as of September 30, 2021   15,069,587    15    45,981    (432)   (42,476)   3,088 

 

(**) Represents an amount less than $1

 

   Common stock   Additional paid-in   Accumulated other comprehensive   Accumulated   Total stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of July 1, 2020   7,157,836    7    36,599    (536)   (31,277)   4,793 
                               
Stock-based compensation related to options granted to employees and consultants   -    -    225    -    -    225 
Exercise of warrants   75,000   - **    83    -    -    83 
Total comprehensive loss   -    -    -    50    (1,674)   (1,624)
Balance as of September 30, 2020   7,232,836    7    36,907    (486)   (32,951)   3,477 

 

(**) Represents an amount less than $1

 

5
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

U.S. dollars in thousands

 

         
  

Nine-Months Ended

September 30,

 
   2021   2020 
Cash flows from operating activities:          
Net loss   (7,805)   (4,437)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   31    28 
Amortization of operating lease right-of-use asset   32    31 
Revaluation of warrants and derivatives   (1)   2 
Revaluation of investment in marketable securities   (46)   (18)
Expense arising from restricted shares issued to compensate waiver by a shareholder   2,618    - 
Stock based compensation   350    388 
(Increase) decrease in accounts receivables   (9)   5 
Decrease in other receivables and prepaid expenses   359    218 
Increase (decrease) in trade payable   176    (10)
Increase in accounts payable   311    2 
           
Net cash used in operating activities   (3,984)   (3,791)
           
Cash flows from investing activities:          
Change in restricted deposits   184    (170)
Investment in right-of-use asset   -    (25)
Purchase of property and equipment   (12)   (14)
           
Net cash provided by (used in) investing activities   172    (209)
           
Cash flows from financing activities:          
Proceeds from issuance of shares, net of issuance costs   5,035    6,094 
Proceeds from Exercise of warrants   822    - 
           
Net cash provided by financing activities   5,857    6,094 
           
Effect of exchange rate fluctuations on cash and cash equivalents   (10)   44 
           
Increase in cash, cash equivalents and restricted cash   2,035    2,138 
Cash, cash equivalents and restricted cash at the beginning of the period   1,774    1,466 
           
Cash, cash equivalents and restricted cash at the end of the period   3,809    3,604 
           
Non cash activities:          
Restricted shares issued to shareholder   2,618    - 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

6
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 1 - General

 

  a.

My Size, Inc. is developing unique measurement technologies based on algorithms with applications in a variety of areas, from the apparel e-commerce market, to the courier services market and to the Do It Yourself smartphone and tablet apps market. The technology is driven by proprietary algorithms which are able to calculate and record measurements in a variety of novel ways.

 

The Company has three subsidiaries, My Size Israel 2014 Ltd (“My Size Israel”) and Topspin Medical (Israel) Ltd., both of which are incorporated in Israel and My Size LLC which was incorporated in the Russian Federation. References to the Company include the subsidiaries unless the context indicates otherwise.

     
  b.

During the nine month period ended September 30, 2021, the Company has incurred significant losses and negative cash flows from operations and has an accumulated deficit of $42,476. The Company has financed its operations mainly through fundraising from various investors.

 

Taking into account the proceeds from warrant exercises and the Company’s financing in October 2021 described in note 7b below, management’s believes that cash on hand will be sufficient to meet its obligations for a period which is longer than 12 months. 

     
  c.

Further to note 1b of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020:

 

On May 26, 2021, the Company, My Size Israel and Shoshana Zigdon entered into an Amendment to Purchase Agreement (the “Amendment”) which made certain amendments to a Purchase Agreement between the parties dated February 16, 2014 (the “Purchase Agreement”). Pursuant to the Amendment, Ms. Zigdon agreed to irrevocably waive the right to repurchase certain assets related to the collection of data for measurement purposes that My Size Israel acquired from Ms. Zigdon under the Purchase Agreement and upon which the Company’s business is substantially dependent, and all past, present and future rights in any of the intellectual property rights sold, transferred and assigned to My Size Israel under the Purchase Agreement and any modifications, amendments or improvements made thereto, including, without limitation, any compensation, reward or any rights to royalties or to receive any payment or other consideration whatsoever in connection with such intellectual property rights (the “Waiver”). In consideration of the Waiver, the Company issued 2,500,000 shares of common stock to Ms. Zigdon in a private placement.

 

The Company measured the fair value of the shares based on the quoted market price of common stock adjusted to reflect the effect of the sales restrictions.

 

During the nine and three month period ended September 30, 2021, an amount of $2,618 and $0 was recorded in research and development expense respectively.

 

Note 2 - Significant Accounting Policies

 

a.    Unaudited condensed consolidated financial statements:

 

The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2021.

   

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2020.

 

b.   Use of estimates:

 

The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.

 

7
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments

 

Fair value of financial instruments:

 

Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company’s own credit risk.

 

In accordance with ASC 820 when measuring the fair value, an entity shall take into account the characteristics of the asset or liability if a market participant would take those characteristics into account when pricing the asset or liability at the measurement date. Such characteristics include, for example:

 

  a. The condition and location of the asset.
     
  b. Restrictions, if any, on the sale or the use of the asset.

 

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

  Level 1 - Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
     
  Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
     
  Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

 

The carrying amounts of cash and cash equivalents, accounts receivable, other receivables, trade payables and accounts payable approximate their fair value due to the short-term maturities of such instruments.

 

The Company holds share certificates in iMine Corporation (“iMine”) formerly known as Diamante Minerals, Inc., a publicly-traded company on the OTCQB.

 

Due to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.

 

   September 30, 2021 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    105    - 

 

 

8
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments (Cont.)

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    59    - 

 

(*) For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $46 and $24, and $18 and $3, respectively.

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial liabilities               
                
Derivatives   -    1    - 

 

Note 4 - Stock Based Compensation

 

The stock-based expense equity awards recognized in the financial statements for services received is related to Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:

 

  

Nine months ended

September 30,

  

Three months ended

September 30,

 
   2021   2020   2021   2020 
                 
Stock-based compensation expense - Research and development   103    126    33    75 
Stock-based compensation expense - Sales and marketing   164    87    71    41 
Stock-based compensation expense - General and administrative   83    175    14    109 
                     
    350    388    118    225 

 

Warrants issued to consultants:

 

  a.

In May 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed upon the three-month anniversary of the agreement to issue to the consultant a (i) a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $1.50 per share and expiring on December 31, 2022, and (ii) a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $2.00 per share and expiring on December 31, 2022.

 

During the nine and three month period ended September 30, 2021, an amount of $63, and $25, respectively, was recorded by the Company as stock option compensation expense with respect to the consultant.

     

 

 

 b.

In June 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed to issue to the consultant a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $1.50 per share and expiring on December 31, 2022.

 

During the nine and three month period ended September 30, 2021, an amount of $34 and $25 was recorded by the Company as stock option compensation expense with respect to the consultant.

     
  c. During the nine month period ended September 30, 2021, the Company issued 150,000 warrants to consultants, no such warrants were exercised and warrants to purchase 3,667 shares expired.

 

The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded under sales and marketing was $116, $56, $8 and $3 respectively and under general and administrative was $0, $0, $17 and $5, respectively.

 

9
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 4 - Stock Based Compensation (Cont.)

 

Stock Option Plan for Employees:

 

In March 2017, the Company adopted the My Size, Inc. 2017 Equity Incentive Plan (the “2017 Employee Plan”) pursuant to which the Company’s Board of Directors may grant stock options to officers and key employees. The total number of options which may be granted to directors, officers, employees under this plan, was initially limited to 200,000 shares of common stock. Stock options can be granted with an exercise price equal to or less than the stock’s fair market value at the grant date. As further described below, in August 2020, the Company’s shareholders approved an increase in the number of shares available for issuance under the Plan to 1,450,000.

 

On May 25, 2020, the compensation committee of the Board of Directors of the Company reduced the exercise price of outstanding options of employees and directors of the Company for the purchase of an aggregate of 140,237 shares of common stock of the Company (with exercise prices ranging between $18.15 and $9.15) to $1.04 per share, which was the closing price for the Company’s common stock on May 22, 2020, and extended the term of the foregoing options for an additional one year from the original date of expiration. The incremental compensation cost resulting from the repricing was $53, and the expenses during the nine and three month period ended September 30, 2021 were $2 and $1, respectively and the expenses during both the nine and three months ended September 30, 2020 were $47 and $4, respectively.

 

On August 10, 2020, the Company’s shareholders approved an increase in the shares available for issuance under the 2017 Employee Plan from 200,000 to 1,450,000 shares. As a result and pursuant to approval of the Company’s compensation committee that was contingent on the foregoing shareholder approval, the number of shares available for issuance under the Company’s 2017 Consultant Incentive Plan was reduced from 466,667 to 216,667 shares.

 

During the nine and three month period ended September 30, 2021, the Company granted an aggregate of 97,500 of stock options under the 2017 Employee Plan, 4,458 options were exercised and options to purchase 40,777 and 19,167 shares of common stock, respectively, expired.

 

The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded was $234 and $62, and $312 and $209, respectively.

 

10
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 5 - Contingencies and Commitments

 

  a.

On August 7, 2018, the Company commenced an action against North Empire LLC (“North Empire”) in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement (the “Agreement”) in which it is seeking damages in an amount to be determined at trial, but in no event less than $616,000. On August 2, 2018, North Empire filed a Summons with Notice against the Company, also in the same Court, in which they allege damages in an amount of $11.4 million arising from an alleged breach of the Agreement. On September 6, 2018 North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by the Company against them, alleging that the Company failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958,589. North Empire also filed a third-party complaint against the Company’s CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, the Company filed a reply to North Empire’s counterclaims. On November 15, 2018, the Company’s CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims.

 

The Company believes it is more likely than not that the counterclaims will be denied.

     
  b.

On July 5, 2021, the Company was served with a legal complaint filed by Fidelity Venture Capital Ltd. and Dror Atzmon in the Magistrate’s Court in Tel Aviv for a monetary award in an amount of NIS 1,436,679 (approximately $450,000) and a declaratory relief. The plaintiffs allege that the Company breached its contractual obligations to pay them for services allegedly rendered to the Company by the plaintiffs under a certain consulting agreement dated July 2, 2014, in an amount of NIS 819,000 (approximately $256,000). Additionally, the plaintiffs allege that the Company should compensate them for losses allegedly incurred by them following their investment in the Company’s shares issued under a certain private offering. In the alternative, the plaintiffs move that the court will declare the investment agreement void with full restitution of plaintiffs’ original investment in an amount of NIS 1,329,650 (approximately $415,000). The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022.

 

At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted the Company cannot evaluate the chances of the claim to succeed.

     
  c.

In May 2021, the Company received notice from Custodian Ventures, LLC (“Custodian”) of its intention to nominate four candidates to stand for election to our board of directors at the Company’s 2021 annual meeting of stockholders. Custodian subsequently made a book and records request and has made public statements calling for changes to our management.

 

 On September 22, 2021, Custodian commenced an action in the Court of Chancery of the State of Delaware captioned, Custodian Ventures, LLC v. MySize, Inc. (the “Delaware Action”). In the Delaware Action, Custodian sought an order from the Court of Chancery pursuant to Section 211 of the General Corporation Law of the State of Delaware compelling us to hold an annual meeting. On November 4, 2021, the Company entered into a settlement agreement (the “Settlement Agreement”) with Custodian and certain affiliates and director nominees (collectively, the “Lazar Parties”) settling and dismissing the Delaware Action (see note 7c).

 

On October 19, 2021, the Company commenced an action in the United States District Court for the Southern District of New York against Custodian, Activist Investing LLC, Milton C. Ault III, Ault Alpha LP, Ault Alpha GP LLC, Ault Capital Management LLC, Ault & Company Inc., David Aboudi, Patrick Loney and David Nathan, , pursuant to Sections 13(d) and 14(a) of the Securities Exchange Act of 1934, and certain rules promulgated thereunder (the “SDNY Action”). The complaint sought, among other things, declaratory and injunctive relief related to defendants’ efforts to nominate a slate of directors for election at our next annual meeting. The complaint alleged that the defendants formed an undisclosed “group” for purposes of Section 13(d) and has misrepresented its true purpose in purchasing My Size, Inc. stock in filings made with the SEC. In addition, the complaint alleged that the defendants engaged in an unlawful solicitation of investors in violation of the Exchange Act proxy rules in connection with their efforts to elect a slate of directors to the Company’s board of directors. On October 20, 2021, the Court signed an order granting a hearing on an anticipated motion for a preliminary injunction and expedited scheduling and discovery in aid thereof, and scheduled that hearing for December 2, 2021. On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties settling and dismissing the claims asserted in the SDNY Action and the Delaware Action against one another (see note 7c). On November 8, 2021, the remaining defendants in the SDNY Action filed and answer and counterclaim asserting a claim against the Company pursuant to New York Civil Rights Law Section 70-a, also known as New York’s anti-SLAPP statute.

 

Note 6 - Significant Events During the Reporting Period

 

  a. On January 8, 2021, the Company conducted a public offering of its securities pursuant to which it issued 1,569,179 shares of its common stock for gross proceeds of $2,008. The net proceeds to the Company from the offering were approximately $1,700, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.
     
  b. In January and February 2021, a holder of warrants exercised warrants to purchase 725,000 ordinary shares of the Company in exchange for $797.
     
  c. On March 25, 2021, the Company conducted a public offering of its shares of common stock pursuant to which it issued 2,618,532 shares of its common stock for gross proceeds of $3,300. The net proceeds to the Company from the offering were approximately $2,872, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.
     
  d. On May 7, 2021, the Company issued an additional 392,780 shares of the Company’s common stock in connection with the full exercise of the underwriter’s overallotment option granted in the Company’s March 2021 public offering. These additional shares were sold to the underwriter at a public offering price of $1.26 per share, resulting in additional net proceeds to the Company, net of the underwriting discount, of approximately $463.
     
  e. On May 26, 2021, the Company issued 2,500,000 shares of common stock to Ms. Zigdon in consideration of the Waiver. See note 1(c) above.
     
  f. In late 2019, a novel strain of COVID-19, also known as coronavirus, was reported in Wuhan, China. While initially the outbreak was largely concentrated in China, spread globally. Many countries around the world, including in Israel, have from time to time significant governmental measures being implemented to control the spread of the virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material limitations on the conduct of business. These measures have resulted in work stoppages and other disruptions. The Company has implemented remote working and work place protocols for its employees in accordance with government requirements. In addition, while the Company has seen an increased demand for MySizeID, the COVID-19 pandemic has had a particularly adverse impact on the retail industry and this has resulted in an adverse impact on the Company’s marketing and sales activities. For example, the Company has three ongoing pilots with international retailers that have been halted, the Company is unable to participate physically in industry conferences, its ability to meet with potential customers is limited and in certain instances sales processes have been delayed or cancelled. The extent to which COVID-19 continues to impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain COVID-19 or treat its impact.

 

Note 7 - Events Subsequent to the balance sheet date

 

  a. On October 26, 2021, holders of warrants exercised an aggregate of 2,625,908 shares of common stock in consideration for $2,889.
     
  b. On October 28, 2021, the Company sold in a registered direct offering 2,514,800 shares of its common stock and, in a concurrent private placement, an aggregate of 1,886,100 unregistered warrants to purchase shares of common stock, at an offering price of $1.352 per share and associated warrant. In addition, on the same day, the Company sold in a private placement 3,772,208 unregistered shares of common stock and unregistered warrants to purchase up to an aggregate of 2,829,156 shares of common stock at the same purchase price as in the registered direct offering. The warrants are immediately exercisable and will expire five years from issuance at an exercise price of $1.26 per share, subject to adjustment as set forth therein.The gross proceeds from the offerings were $8,500. The net proceeds to the Company from the offerings were approximately $7,560, after deducting placement agent’s fees and other estimated offering expenses payable by the Company. In connection with the offerings, the Company issued to the placement agent warrants to purchase 440,091 shares on substantially the same terms as the purchasers in the offerings at an exercise price of $1.69 per share and a term expiring on October 26, 2026.

 

   
  c. On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties. Pursuant to the Settlement Agreement, the Company and the Lazar Parties agreed to compromise and settle the Delaware Action and SDNY Action. In addition, pursuant to the Settlement Agreement, the Company agreed to reimburse Custodian for out of pocket expenses and in consideration for the dismissal and release of claims against the Company an aggregate amount equal to $275, to be paid within three business days of the effective date of the Settlement Agreement. With respect to the Company’s 2021 annual meeting of stockholders, Custodian agreed to, among other things, withdraw or rescind (i) its May 12, 2021 notice of stockholder nominations of four director candidates with respect to the Company’s 2021 annual meeting of stockholders, (ii) the notice dated October 28, 2021 submitted by Custodian to the Company notifying the Company of Custodian’s continued intent to bring its nomination of four director candidates before the Company’s stockholders at the 2021 annual meeting, and (iii) any and all related materials and notices submitted to the Company in connection therewith or related thereto and to not take any further action in connection with the solicitation of any proxies in connection with the Company. Custodian also agreed to cease any and all solicitation and other activities in connection with the 2021 annual meeting. In addition, Custodian agreed to certain customary standstill provisions for a period of five years beginning on the effective date of the Agreement (the “Standstill Period”). The Settlement Agreement also provides that during the Standstill Period, the Lazar Parties will vote all shares of common stock of the Company it beneficially owns in in accordance with any proposal or recommendation made by the Company or the Board of Directors of the Company that is submitted to the stockholders of the Company, unless to do so would violate applicable law and except with respect to certain extraordinary transactions. The Settlement Agreement also contains non-disparagement and confidentiality provisions, subject to certain exceptions.

 

11
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis provides information that we believe to be relevant to an assessment and understanding of our results of operations and financial condition for the periods described. This discussion should be read together with our condensed consolidated interim financial statements and the notes to the financial statements, which are included in this Quarterly Report on Form 10-Q. This information should also be read in conjunction with the information contained in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission on March 29, 2021, or the Annual Report, including the consolidated annual financial statements as of December 31, 2020 and their accompanying notes included therein.

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our common stock and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement.

 

Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this Quarterly Report on Form 10-Q. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:

 

  ● our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all;
     
  ● our ability to continue as a going concern;
     
  ● risks related to the COVID-19 pandemic;
     
  ● the new and unproven nature of the measurement technology markets;
     
  ● our ability to achieve customer adoption of our products;
     
  ● our dependence on assets we purchased from a related party and the risk that such assets may in the future be repurchased;
     
  ● our ability to enhance our brand and increase market awareness;
     
  ● our ability to introduce new products and continually enhance our product offerings;
     
  ● the success of our strategic relationships with third parties;
     
  ● information technology system failures or breaches of our network security;
     
  ● competition from competitors;
     
  ● our reliance on key members of our management team;
     
  ● current or future litigation; and
     
  ● the impact of the political and security situation in Israel on our business.

 

12
 

 

The foregoing list sets forth some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. You should read this Quarterly Report on Form 10-Q and the documents that we reference herein and have filed as exhibits to the Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this Quarterly Report on Form 10-Q is accurate as of the date hereof. Because the risk factors referred to on page 12 of our Annual Report, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this Quarterly Report on Form 10-Q, and particularly our forward-looking statements, by these cautionary statements.

 

Unless the context otherwise requires, all references to “we,” “us,” “our” or “the Company” in this Quarterly Report on Form 10-Q are to My Size, Inc. a Delaware corporation, and its subsidiaries, including MySize Israel 2014 Ltd, Topspin Medical (Israel) Ltd and My Size LLC. taken as a whole.

 

Overview

 

We are a creator of mobile device measurement solutions that has developed innovative solutions designed to address shortcomings in multiple verticals, including the e-commerce fashion/apparel, shipping/parcel and do it yourself, or DIY, industries. Utilizing our sophisticated algorithms within our proprietary technology, we can calculate and record measurements in a variety of novel ways, and most importantly, increase revenue for businesses across the globe.

 

Our solutions can be utilized to accurately take measurements of a variety of items via a mobile device. By downloading the application to a smartphone, the user is then able to run the mobile device over the surface of an item the user wishes to measure. The information is then automatically sent to a cloud-based server where the dimensions are calculated through our proprietary algorithms, and the accurate measurements (+ or - 2 centimeters) are then sent back to the user’s mobile device. We believe that the commercial applications for this technology are significant in many areas.

 

Currently, we are mainly focusing on the e-commerce fashion/apparel industry. In addition, our solutions address the shipping/parcel and DIY uses markets.

 

While we rollout our products to major retailers and apparel companies, there is a lead time for new customers to ramp up before we can recognize revenue. This lead time varies between customers, especially when the customer is a tier 1 retailer, where the integration process may take longer. Generally, first we integrate our product into a customer’s online platform, which is followed by piloting and implementation, and, assuming we are successful, commercial roll-out, all of which takes time before we expect it to impact our financial results in a meaningful way. While we have begun generating initial sales revenue, we do not expect to generate meaningful revenue during the upcoming quarters. Because of the numerous risks and uncertainties associated with the success of our market penetration and our dependence on the extent to which MySizeID is adopted and utilized, we are unable to predict the extent to which we will recognize revenue. We may be unable to successfully develop or market any of our current or proposed products or technologies, those products or technologies may not generate any revenues, and any revenues generated may not be sufficient for us to become profitable or thereafter maintain profitability.

 

13
 

 

Important Information about COVID-19

 

In late 2019, a novel strain of COVID-19, also known as coronavirus, was reported in Wuhan, China. While initially the outbreak was largely concentrated in China, it spread globally. Many countries around the world, including in Israel, have from time to time significant governmental measures implemented to control the spread of the virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material limitations on the conduct of business. These measures have resulted in work stoppages and other disruptions. We implemented remote working and work place protocols for our employees in accordance with Israeli government requirements. In addition, while we have seen an increased demand for MySizeID, the COVID-19 pandemic has had a particularly adverse impact on the retail industry and this has resulted in an adverse impact on our marketing and sales activities. For example, we have three ongoing pilots with international retailers that have been halted, we are unable to participate physically in industry conferences, our ability to meet with potential customers is limited, and in certain instances sales processes have been delayed or cancelled. The extent to which COVID-19 continues to impact our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain COVID-19 or treat its impact.

 

Results of Operations

 

The table below provides our results of operations for the periods indicated.

 

  

Three months ended

September 30

  

Nine months ended

September 30

 
   2021   2020   2021   2020 
   (dollars in thousands)   (dollars in thousands) 
Revenues  $31   $88   $88   $139 
Cost of revenues   -    (1)   -    (2)
Gross profit   31    87    88    137 
Research and development expenses   (462)   (397)   (3,842)   (1,085)
Sales and marketing   (521)   (555)   (1,798)   (1,632)
General and administrative   (1,074)   (777)   (2,303)   (1,855)
Operating loss   (2,026)   (1,642)   (7,855)   (4,435)
Financial income (expenses), net   18    (32)   50    (2)
Net loss  $(2,008)  $(1,674)  $(7,805)  $(4,437)

 

Nine and Three Months Ended September 30, 2021 Compared to Nine and Three Months Ended September 30, 2020

 

Revenues

 

We started to generate revenue in 2019 and we expect to incur additional losses to increase our sales and marketing efforts and to perform further research and development activities. Our revenues for the nine months ended September 30, 2021 amounted to $88,000 compared to $139,000 for the nine months ended September 30, 2020.

 

Our revenues for the three months ended September 30, 2021 amounted to $31,000 compared to $88,000 for the three months ended September 30, 2020. The decrease in both nine and three months corresponding period primarily resulted from fees from customer projects in the corresponding period compared to none during the nine and three month ended September 30, 2021, offset by increase in traffic, as measured by the MySizeID engine per its license agreements.

 

14
 

 

Research and Development Expenses

 

Our research and development expenses for the nine months ended September 30, 2021 amounted to $3,842,000 compared to $1,085,000 for the nine months ended September 30, 2020. The increase from the corresponding period primarily resulted from share based payment in amount of $2,618,000 attributed to the share issuance to Shoshana Zigdon under that certain Amendment to Purchase Agreement dated May 26, 2021.

 

Our research and development expenses for the three months ended September 30, 2021 amounted to $462,000 compared to $397,000 for the three months ended September 30, 2020. The increase from the corresponding period primarily resulted from the hiring of new employees and increase in expenses to subcontractors.

 

Sales and Marketing Expenses

 

Our sales and marketing expenses for the nine months ended September 30, 2021 amounted to $1,798,000 compared to $1,632,000 for the nine months ended September 30, 2020. The increase in comparison with the corresponding period was mainly due to an increase in payments to consultants, share-based payments and hiring new sales consultants offset by decrease in travel and marketing expenses.

 

Our sales and marketing expenses for the three months ended September 30, 2021 amounted to $521,000 compared to $555,000 for the three months ended September 30, 2020. The decrease in comparison with the corresponding period was mainly due to a decrease in marketing expenses offset by an increase in share-based payments.

 

General and Administrative Expenses

 

Our general and administrative expenses for the nine months ended September 30, 2021 amounted to $2,303,000 compared to $1,855,000 for the nine months ended September 30, 2020. The increase in comparison with the corresponding period was mainly due to an increase in professional services, insurance expenses and settlement expenses with the Lazar Parties (as defined below) offset by a decrease in shared-based payments.

 

Our general and administrative expenses for the three months ended September 30, 2021 amounted to $799,000 compared to $1,074,000 for the three months ended September 30, 2020. The increase in comparison with the corresponding period was mainly due to an increase in professional expenses, mainly attributed to the proxy fight including settlement expenses with the Lazar Parties offset by a decrease in shared-based payments.

 

Operating Loss

 

As a result of the foregoing, for the nine month ended September 30, 2021, our operating loss was $7,855,000, an increase of $3,420,000, or 77%, compared to our operating loss for the nine month ended September 30, 2020 of $4,435,000. The increase from the corresponding period primarily resulted from share based payment in amount of $2,618,000 attributed to the share issuance to Shoshana Zigdon under that certain Amendment to Purchase Agreement dated May 26, 2021.

 

As a result of the foregoing, for the three month ended September 30, 2021, our operating loss was $2,026,000, compared to our operating loss for the three month ended September 30, 2020 of $1,642,000.

 

Financial Income, Net

 

Our financial income, net for the nine months ended September 30, 2021 amounted to $50,000 as opposed to financial expenses of $2,000 for the nine months ended September 30, 2020. During the nine months ended September 30, 2021, financial income derived mainly from revaluation of investment in marketable securities whereas in the corresponding period, we had financial expenses mainly derived from exchange rate differences offset by financial income mainly from revaluation of investment in marketable securities.

 

Our financial income, net for the three months ended September 30, 2021 amounted to $18,000 compared to financial expense of $32,000 for the three months ended September 30, 2020. During the three months ended September 30, 2021, financial income mainly derived from revaluation of investment in marketable securities whereas in the corresponding period we had financial expenses mainly from revaluation of derivatives and from exchange rate expenses.

 

Net Loss

 

As a result of the foregoing research and development, sales and marketing, general and administrative expenses initial revenues, and financial income, our net loss for the nine months ended September 30, 2021 was $7,805,000 compared to net loss of $4,437,000 for the nine months ended September 30, 2020, the increase in the net loss was mainly due to the reasons mentioned above.

 

As a result of the foregoing research and development, sales and marketing, general and administrative expenses initial revenues, and financial expenses, our net loss for the three months ended September 30, 2021 was $2,008,000, compared to net loss of $1,674,000 for the three months ended September 30, 2020, the increase in the net loss was mainly due to the reasons mentioned above.

 

Liquidity and Capital Resources

 

Since our inception, we have funded our operations primarily through public and private offerings of debt and equity in the State of Israel and in the U.S.

 

As of September 30, 2021, we had cash, cash equivalents, restricted cash of $3,809,000 compared to $1,774,000 of cash, cash equivalents and restricted cash as of December 31, 2020. This increase primarily resulted from the public offerings that we completed in January and March 2021, including the overallotment that closed in May 2021, and proceeds from warrants that were exercised, as further described below.

 

On October 28, 2021, we sold in a registered direct offering 2,514,800 shares of our common stock and, in a concurrent private placement, an aggregate of 1,886,100 unregistered warrants to purchase shares of common stock, at an offering price of $1.352 per share and associated warrant. In addition, on the same day, we sold in a private placement of our securities 3,772,208 unregistered shares of common stock and unregistered warrants to purchase up to an aggregate of 2,829,156 shares of common stock at the same purchase price as in the registered direct offering. The warrants are immediately exercisable and will expire five years from issuance at an exercise price of $1.26 per share, subject to adjustment as set forth therein. The gross proceeds from the offerings were $8,500,000. The net proceeds to us from the offering were approximately $7,560,000 after deducting placement agent’s fees and other estimated offering expenses payable by the Company.

 

On October 26, 2021, holders of warrants exercised an aggregate of 2,625,908 shares of common stock in consideration for $2,889,000.

 

On March 25, 2021, we completed an underwritten public offering of our common stock pursuant to which we issued 2,618,532 shares of our common stock at a public offering price of $1.26 per share for gross proceeds of approximately $3,300,000. We received net proceeds of approximately $2,872,000, after deducting the underwriting discounts and commissions and estimated offering expenses. On May 7, 2021, we issued an additional 392,780 shares of our common stock in connection with the full exercise of the underwriter’s overallotment option granted in the March 2021 public offering. These additional shares were sold to the underwriter at a public offering price of $1.26 per share, resulting in additional net proceeds, after deducting the underwriting discount, of $463,260.

 

Prior to that, on January 8, 2021, we completed an underwritten public offering of our common stock pursuant to which we issued 1,569,179 shares of our common stock at a public offering price of $1.28 per share for gross proceeds of approximately $2,008,000. We received net proceeds of approximately $1,700,000, after deducting the underwriting discounts and commissions and estimated offering expenses. Furthermore, in January and February 2021, a holder of warrants exercised warrants to purchase 725,000 of our ordinary shares in exchange for $797,000.

 

Cash used in operating activities amounted to $3,984,000 for the nine months ended September 30, 2021, compared to $3,791,000 for the nine months ended September 30, 2020.

 

Net cash provided by investing activities was $172,000 for the nine months ended September 30, 2021, compared to $209,000 (used in) investing activities for the nine months ended September 30, 2020.

 

Net cash provided by financing activities was $5,857,000 for the nine months ended September 30, 2021, compared to $6,094,000 for the nine months ended September 30, 2020. The cash flow from financing activities for the nine months ended September 30, 2021 resulted from the public offerings that occurred in January 2021 and March 2021, including the full exercise of the underwriter’s overallotment option that occurred in May 2021 and from proceeds that were received from an investor for warrants that were exercised.

 

15
 

 

We do not have any material commitments for capital expenditures during the next twelve months.

 

We expect to continue to generate losses and negative cash flows from operations for the foreseeable future and expect to need to obtain additional funds in the future. Based on the projected cash flows, the proceeds from the October 2021 offerings and warrant exercises, and cash balances as of September 30, 2021, management believes that the cash on hand will be sufficient to meet its obligations for a period which is longer than 12 months. However, we will need to raise additional capital, which may not be available on reasonable terms or at all. Additional capital would be used to accomplish the following:

 

  ● finance our current operating expenses;
     
  ● pursue growth opportunities;
     
  ● hire and retain qualified management and key employees;
     
  ● respond to competitive pressures;
     
  ● comply with regulatory requirements; and
     
  ● maintain compliance with applicable laws and exchange rules.

 

Current conditions in the capital markets are such that traditional sources of capital may not be available to us when needed or may be available only on unfavorable terms. Our ability to raise additional capital, if needed, will depend on conditions in the capital markets, the COVID-19 pandemic, economic conditions shareholder activism and a number of other factors, many of which are outside our control, and on our financial performance. Accordingly, we cannot assure you that we will be able to successfully raise additional capital at all or on terms that are acceptable to us. If we cannot raise additional capital when needed, it may have a material adverse effect on our business, results of operations and financial condition.

 

To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities could result in substantial dilution for our current stockholders. The terms of any securities issued by us in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then-outstanding. We may issue additional shares of our common stock or securities convertible into or exchangeable or exercisable for our common stock in connection with hiring or retaining personnel, option or warrant exercises, future acquisitions or future placements of our securities for capital-raising or other business purposes. The issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our common stock to decline and existing stockholders may not agree with our financing plans or the terms of such financings. In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition. Furthermore, any additional debt or equity financing that we may need may not be available on terms favorable to us, or at all. If we are unable to obtain such additional financing on a timely basis, we may have to curtail our development activities and growth plans and/or be forced to sell assets, perhaps on unfavorable terms, or we may have to cease our operations, which would have a material adverse effect on our business, results of operations and financial condition.

 

Off-Balance Sheet Arrangements

 

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

 

Application of Critical Accounting Policies and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses during the reporting periods. Actual results may differ from these estimates under different assumptions or conditions.

 

While our significant accounting policies are more fully described in the notes to our financial statements appearing elsewhere in this report, we believe that the accounting policies discussed below are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because information was not available at the time or it included matters that were highly uncertain at the time we were making our estimate; and (2) changes in the estimate could have a material impact on our financial condition or results of operations.

 

16
 

 

Revenue from Contracts with Customers

 

The Company implemented ASC 606, Revenue from Contract with Customers.

 

To recognize revenue under ASC 606, the Company applies the following five steps:

 

  1. Identify the contract with a customer. A contract with a customer exists when the Company enters into an enforceable contract with a customer and the Company determines that collection of substantially all consideration for the services is probable.
     
  2. Identify the performance obligations in the contract.
     
  3. Determine the transaction price. The transaction price is determined based on the consideration to which the Company will be entitled in exchange for providing the service to the customer.
     
  4. Allocate the transaction price to performance obligations in the contract. If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation.
     
  5. Recognize revenue when or as the Company satisfies a performance obligation. When the Company provides a service, revenue is recognized over the service term.

 

The Company’s revenue is derived from the sale of cloud-enabled software subscriptions, associated software maintenance and support.

 

Revenue is recognized when a contract exists between the Company and a customer (business) and upon transfer of control of promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of products and services, which may be capable of being distinct and accounted for as separate performance obligations. In case of offerings such as cloud-enabled subscription, other service elements in the contract are generally delivered concurrently with the subscription services and therefore revenue is recognized in a similar manner as the subscription services.

 

Product, Subscription and Services Offerings

 

Such performance obligations includes cloud-enabled subscriptions, software maintenance, training and technical support.

 

Fully hosted subscription services (SaaS) allow customers to access hosted software during the contractual term without taking possession of the software. Cloud-hosted subscription services are sold on a fee-per-subscription that is based on consumption or usage (per fit recommendation).

 

We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Fees based on a number of transactions or impressions per month, are allocated to the period in which the transactions occur. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service.

 

17
 

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

 

Not required for a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the rules and regulations thereunder, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

As required by Rule 13a-15(b) under the Exchange Act, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2021. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of September 30, 2021 were effective.

 

Our Chief Executive Officer and Chief Financial Officer do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

Changes in Internal Controls

 

During the most recent fiscal quarter, no change has occurred in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18
 

 

Part II – Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

On August 7, 2018, we commenced an action against North Empire LLC, or North Empire, in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement or Agreement in which we are seeking damages in an amount to be determined at trial, but in no event less than $616,000. On August 2, 2018, North Empire filed a Summons with Notice against us, also in the same Court, in which they allege damages in an amount of $11.4 million arising from an alleged breach of the Agreement. On September 6, 2018, North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by us against them, alleging that we failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958,589. North Empire also filed a third-party complaint against our CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, we filed a reply to North Empire’s counterclaims. On November 15, 2018, our CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims.

 

On July 5, 2021, we were served with a legal complaint filed by Fidelity Venture Capital Ltd. and Dror Atzmon in the Magistrate’s Court in Tel Aviv for a monetary award in an amount of NIS 1,436,679 and declaratory relief. The plaintiffs allege that we breached our contractual obligations to pay them for services allegedly rendered to us by the plaintiffs under a certain consulting agreement in an amount of NIS 819,000. Additionally, the plaintiffs allege that we should compensate them for losses allegedly incurred by them following their investment in our shares issued under a certain private offering. In the alternative, the plaintiffs move that the court will declare the investment agreement void with full restitution of plaintiffs’ original investment in an amount of NIS 1,329,650. We filed our statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for Janua1y 23 2022. At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted, we cannot evaluate the chances of the claim to succeed.

 

On September 22, 2021, Custodian Ventures, LLC, or Custodian, commenced an action in the Court of Chancery of the State of Delaware captioned, Custodian Ventures, LLC v. Mysize, Inc., C.A. No. 2021-0817-LWW, or the Delaware Action. In the Delaware Action, Custodian sought an order from the Court of Chancery pursuant to Section 211 of the General Corporation Law of the State of Delaware compelling us to hold an annual meeting. On November 4, 2021, we entered into a settlement agreement, or the Settlement Agreement, with Custodian, Activist Investing LLC, David Aboudi, Partick Loney and David Natan, collectively, the Lazar Parties, settling and dismissing the Delaware Action.

 

On October 19, 2021, we commenced an action in the United States District Court for the Southern District of New York captioned My Size, Inc. v. David Lazar, Custodian Ventures LLC, Activist Investing LLC, Milton C. Ault III, Ault Alpha LP, Ault Alpha GP LLC, Ault Capital Management LLC, Ault & Company Inc., David Aboudi, Patrick Loney and David Nathan, Civil Action No, 1:21-cv-08585, pursuant to Sections 13(d) and 14(a) of the Securities Exchange Act of 1934, and certain rules promulgated thereunder, or the SDNY Action. The complaint sought, among other things, declaratory and injunctive relief related to defendants’ efforts to nominate a slate of directors for election at our next annual meeting of. The complaint alleged that the defendants formed an undisclosed “group” for purposes of Section 13(d) and has misrepresented its true purpose in purchasing My Size, Inc. stock in filings made with the SEC. In addition, the complaint alleged that the defendants engaged in an unlawful solicitation of investors in violation of the Exchange Act proxy rules in connection with their efforts to elect a slate of directors to our board of directors. On October 20, 2021, the Court signed an order granting a hearing on an anticipated motion for a preliminary injunction and expedited scheduling and discovery in aid thereof, and scheduled that hearing for December 2, 2021. On November 4, 2021, we entered into the Settlement Agreement with the Lazar Parties settling and dismissing the claims asserted in the SDNY Action and the Delaware Action against one another. On November 8, 2021, the remaining defendants in the SDNY Action filed and answer and counterclaim asserting a claim against us pursuant to New York Civil Rights Law Section 70-a, also known as New York’s anti-SLAPP statute.

 

Item 1A. Risk Factors.

 

Not required for a smaller reporting company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

19
 

 

Item 6. Exhibits.

 

Exhibit Number   Description of Exhibits
     
31.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Schema
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
101.LAB*   Inline XBRL Taxonomy Label Linkbase
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
104*   Cover Page Interactive Data File (formatted as Inline XBRL document and contained in Exhibit 101)

 

* Filed herewith

 

20
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  My Size, Inc.
     
Date: November 15, 2021 By: /s/ Ronen Luzon
    Ronen Luzon
   

Chief Executive Officer

(Principal Executive Officer)

     
Date: November 15, 2021 By: /s/ Or Kles
    Or Kles
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

21
 EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the

Securities Exchange Act of 1934

 

I, Ronen Luzon certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of My Size, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2021 By: /s/ Ronen Luzon
    Ronen Luzon
    Chief Executive Officer
(Principal Executive Officer)

 

 
 EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the

Securities Exchange Act of 1934

 

I, Or Kles, certify that:

 

1 I have reviewed this Quarterly Report on Form 10-Q of My Size, Inc.;
   
2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
   b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
     
   d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
   b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2021 By: /s/ Or Kles
    Or Kles
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 
 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of My Size, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ronen Luzon, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Company’s Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: November 15, 2021 By: /s/ Ronen Luzon
    Ronen Luzon
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of My Size, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Or Kles, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Company’s Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: November 15, 2021 By: /s/ Or Kles
    Or Kles
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 
 EX-101.SCH 6 mysz-20210930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Interim Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Contingencies and Commitments link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Significant Events During the Reporting Period link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Events Subsequent to the balance sheet date link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Schedule of Fair value of Financial Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Schedule of Stock Based Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stock Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Contingencies and Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Significant Events During the Reporting Period (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Events Subsequent to the balance sheet date (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mysz-20210930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 mysz-20210930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 mysz-20210930_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Sale of Stock [Axis] Private Placement [Member] Title of Individual [Axis] ShoshanaZigdon [Member] Income Statement Location [Axis] Research and Development Expense [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Consulting Agreement [Member] Consultant [Member] Award Type [Axis] Warrant One [Member] Consultant One [Member] Warrant Two [Member] Warrant [Member] Plan Name [Axis] Two Thousand Seventeen Employee Plan [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Two Thousand Seventeen Consultant Incentive Plan [Member] Series [Axis] North Empire L L C [Member] Securities Purchase Agreement [Member] Fidelity Venture Capital Ltd [Member] Mr.Dror Atzmon [Member] IPO [Member] Over-Allotment Option [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Holders [Member] Settlement Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current Assets: Cash and cash equivalents Restricted cash Restricted deposit Accounts receivable Other receivables and prepaid expenses Total current assets Property and equipment, net Right-of-use asset Investment in marketable securities Total non-current assets Total assets Liabilities and stockholders’ equity Current liabilities: Operating lease liability Trade payables Accounts payable Derivatives Total current liabilities Operating lease liability Total non-current liabilities Total liabilities COMMITMENTS AND CONTINGENCIES Stockholders’ equity: Stock Capital - Common stock of $0.001 par value - Authorized: 100,000,000 shares; Issued and outstanding: 15,069,587 and 7,232,836 as of September 30, 2021 and December 31, 2020, respectively Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Revenue from Contract with Customer [Abstract] Revenues Cost of revenues Gross profit Operating expenses Research and development Sales and marketing General and administrative Total operating expenses Operating loss Financial income (expenses), net Net loss Other comprehensive income (loss): Foreign currency translation differences Total comprehensive loss Basic and diluted loss per share Basic and diluted weighted average number of shares outstanding Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Stock-based compensation related to options granted to employees and consultants Exercise of options granted to employees Exercise of options granted to employees, shares Restricted shares issued to shareholder (*) Restricted shares issued to shareholde, shares Issuance of shares, net of issuance cost of $1,000 Issuance of shares, net of issuance cost of $1,000, shares Exercise of warrants and pre funded warrants Exercise of warrants and pre funded warrants, shares Liability reclassified to equity Exercise of warrants Exercise of warrants, shares Total comprehensive loss Ending balance, value Ending balance, shares Statement of Stockholders' Equity [Abstract] Issuance cost, net Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Amortization of operating lease right-of-use asset Revaluation of warrants and derivatives Revaluation of investment in marketable securities Expense arising from restricted shares issued to compensate waiver by a shareholder Stock based compensation (Increase) decrease in accounts receivables Decrease in other receivables and prepaid expenses Increase (decrease) in trade payable Increase in accounts payable Net cash used in operating activities Cash flows from investing activities: Change in restricted deposits Investment in right-of-use asset Purchase of property and equipment Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from issuance of shares, net of issuance costs Proceeds from Exercise of warrants Net cash provided by financing activities Effect of exchange rate fluctuations on cash and cash equivalents Increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at the beginning of the period Cash, cash equivalents and restricted cash at the end of the period Non cash activities: Restricted shares issued to shareholder Organization, Consolidation and Presentation of Financial Statements [Abstract] General Accounting Policies [Abstract] Significant Accounting Policies Investments, All Other Investments [Abstract] Financial Instruments Share-based Payment Arrangement [Abstract] Stock Based Compensation Commitments and Contingencies Disclosure [Abstract] Contingencies and Commitments Significant Events During Reporting Period Significant Events During the Reporting Period Subsequent Events [Abstract] Events Subsequent to the balance sheet date Unaudited condensed consolidated financial statements Use of estimates Schedule of Fair value of Financial Assets and Liabilities Schedule of Stock Based Expenses Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Retained Earnings (Accumulated Deficit) Stock Issued During Period, Shares, New Issues Research and development expense Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Investment in marketable securities Gain (loss) on marketable securities Derivatives Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants and Rights Outstanding, Maturity Date Shares based compensation Warrants to consultants Number of options expired Stock option compensation Number of options granted Number of shares available for issuance Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Incremental compensation cost [custom:IncrementalCompensationExpenses] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Loss Contingency, Damages Sought, Value Gain (Loss) on Contract Termination Investment Owned, Balance, Principal Amount Other Commitments, Description Stock issued during period, shares issue Proceeds from common stock Net proceeds from from offering Exercise of warrants Exchange of ordinary shares Price per share Underwriting discount Subsequent Event [Table] Subsequent Event [Line Items] Warrants to purchase shares Shares Issued, Price Per Share Warrant expiration term Warrant exercise price per share Proceeds from Issuance Initial Public Offering [custom:NetProceedsFromIssuancePublicOffering] Warrant expiring date Claim amount paid Exercise of warrants. Exercise of warrants, shares. Exercise of warrants and pre funded warrants. Exercise of warrants and pre funded warrants, shares. Issuance cost, net. Revaluation of investment in marketable securities. Revaluation of warrants and derivatives. Increase decrease in trade payable. Change in Restricted Deposits. ShoshanaZigdon [Member] Consulting Agreement [Member] Consultant [Member] Warrant One [Member] Consultant One [Member] Warrant Two [Member] Warrants to Consultants. 2017 Employee Plan [Member] Incremental compensation cost. Incremental compensation expenses. 2017 Consultant Incentive Plan [Member] North Empire LLC [Member] Securities Purchase Agreement [Member] Fidelity Venture Capital Ltd [Member] Mr.Dror Atzmon [Member] Significant Events During the Reporting Period. Exchange of ordinary shares. Underwriting Discount. Unaudited Condensed Consolidated Financial Statements [Policy Text Block] Net proceeds received from offering. Assets, Current Assets, Noncurrent Assets [Default Label] Liabilities, Current Operating Lease, Liability, Noncurrent Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit Selling and Marketing Expense General and Administrative Expense Operating Expenses Operating Income (Loss) Shares, Outstanding RevaluationOfInvestmentInMarketableSecurities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Investments, Fair Value Disclosure Financial Liabilities Fair Value Disclosure EX-101.PRE 10 mysz-20210930_pre.xml XBRL PRESENTATION FILE XML 11 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001211805 2021-01-01 2021-09-30 0001211805 2021-11-10 0001211805 2021-09-30 0001211805 2020-12-31 0001211805 2020-01-01 2020-09-30 0001211805 2021-07-01 2021-09-30 0001211805 2020-07-01 2020-09-30 0001211805 us-gaap:CommonStockMember 2020-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001211805 us-gaap:RetainedEarningsMember 2020-12-31 0001211805 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001211805 2021-01-01 2021-06-30 0001211805 us-gaap:CommonStockMember 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-09-30 0001211805 us-gaap:CommonStockMember 2019-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001211805 us-gaap:RetainedEarningsMember 2019-12-31 0001211805 2019-12-31 0001211805 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001211805 2020-01-01 2020-06-30 0001211805 us-gaap:CommonStockMember 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-09-30 0001211805 2020-09-30 0001211805 us-gaap:CommonStockMember 2021-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001211805 us-gaap:RetainedEarningsMember 2021-06-30 0001211805 2021-06-30 0001211805 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001211805 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001211805 us-gaap:CommonStockMember 2020-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001211805 us-gaap:RetainedEarningsMember 2020-06-30 0001211805 2020-06-30 0001211805 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001211805 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001211805 MYSZ:ShoshanaZigdonMember us-gaap:PrivatePlacementMember 2021-05-25 2021-05-26 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001211805 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001211805 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001211805 MYSZ:ConsultantMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-05-31 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-05-31 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantTwoMember MYSZ:ConsultingAgreementMember 2021-05-31 0001211805 MYSZ:ConsultantOneMember us-gaap:WarrantMember MYSZ:ConsultingAgreementMember 2021-01-01 2021-09-30 0001211805 MYSZ:ConsultantOneMember us-gaap:WarrantMember MYSZ:ConsultingAgreementMember 2021-07-01 2021-09-30 0001211805 MYSZ:ConsultantMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-06-30 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-06-30 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantTwoMember MYSZ:ConsultingAgreementMember 2021-06-30 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-01-01 2021-09-30 0001211805 MYSZ:ConsultantOneMember MYSZ:WarrantOneMember MYSZ:ConsultingAgreementMember 2021-07-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2017-03-01 2017-03-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2020-08-10 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-24 2020-05-25 0001211805 srt:MinimumMember MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-25 0001211805 srt:MaximumMember MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-05-25 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2020-08-09 0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2020-08-09 0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2020-08-10 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2021-01-01 2021-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2021-07-01 2021-09-30 0001211805 MYSZ:SecuritiesPurchaseAgreementMember MYSZ:NorthEmpireLLCMember 2018-08-06 2018-08-07 0001211805 MYSZ:NorthEmpireLLCMember 2018-08-01 2018-08-02 0001211805 MYSZ:NorthEmpireLLCMember 2018-09-26 2018-09-27 0001211805 MYSZ:MrDrorAtzmonMember MYSZ:FidelityVentureCapitalLtdMember 2021-07-04 2021-07-05 0001211805 MYSZ:MrDrorAtzmonMember MYSZ:FidelityVentureCapitalLtdMember 2021-07-05 0001211805 MYSZ:FidelityVentureCapitalLtdMember 2021-07-04 2021-07-05 0001211805 us-gaap:IPOMember 2021-01-07 2021-01-08 0001211805 2021-01-31 0001211805 2021-02-28 0001211805 2021-01-01 2021-01-31 0001211805 2021-01-01 2021-02-28 0001211805 us-gaap:IPOMember 2021-03-24 2021-03-25 0001211805 us-gaap:OverAllotmentOptionMember 2021-05-06 2021-05-07 0001211805 us-gaap:IPOMember 2021-05-07 0001211805 us-gaap:IPOMember 2021-05-06 2021-05-07 0001211805 MYSZ:HoldersMember us-gaap:SubsequentEventMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-10-25 2021-10-26 0001211805 us-gaap:CommonStockMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-26 0001211805 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-25 2021-10-26 0001211805 MYSZ:WarrantOneMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-26 0001211805 us-gaap:SubsequentEventMember 2021-10-28 0001211805 us-gaap:SubsequentEventMember 2021-10-25 2021-10-26 0001211805 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-10-28 0001211805 us-gaap:SubsequentEventMember MYSZ:SettlementAgreementMember 2021-11-03 2021-11-04 iso4217:USD shares iso4217:USD shares iso4217:ILS 0001211805 false --12-31 Q3 P5Y 10-Q true 2021-09-30 2021 false 001-37370 MY SIZE, INC. DE 51-0394637 HaYarden 4 POB 1026 Airport City IL 7010000 +972 3-600-9030 Common Stock, $0.001 par value per share MYSZ NASDAQ Yes Yes Non-accelerated Filer true false false 23982503 3539000 1689000 270000 85000 184000 37000 28000 121000 482000 3967000 2468000 108000 128000 792000 911000 105000 59000 1005000 1098000 4972000 3566000 130000 129000 556000 381000 705000 400000 1000 1391000 911000 493000 579000 493000 579000 1884000 1490000 0.001 0.001 100000000 100000000 15069587 15069587 7232836 7232836 15000 7000 45981000 37164000 -432000 -424000 -42476000 -34671000 3088000 2076000 4972000 3566000 88000 139000 31000 88000 2000 1000 88000 137000 31000 87000 3842000 1085000 462000 397000 1798000 1632000 521000 555000 2303000 1855000 1074000 777000 7943000 4572000 2507000 1729000 -7855000 -4435000 -2026000 -1642000 50000 -2000 18000 -32000 -7805000 -4437000 -2008000 -1674000 -8000 53000 8000 50000 -7813000 -4384000 -2000000 -1624000 -0.62 -0.89 -0.13 -0.23 12546022 4971202 15044184 7217619 7232836 7000 37164000 -424000 -34671000 2076000 350000 350000 4458 2500000 3000 2615000 2618000 768000 4580491 4000 5031000 5035000 751802 1000 821000 822000 -8000 -7805000 -7813000 15069587 15000 45981000 -432000 -42476000 3088000 2085900 2000 30102000 -539000 -28514000 1051000 388000 388000 1000000 2439802 3000 5992000 5995000 2707134 2000 97000 99000 328000 328000 53000 -4437000 -4384000 7232836 7000 36907000 -486000 -32951000 3477000 15038327 15000 45838000 -440000 -40468000 4945000 118000 118000 4458 26802 25000 25000 8000 -2008000 -2000000 15069587 15000 45981000 -432000 -42476000 3088000 7157836 7000 36599000 -536000 -31277000 4793000 225000 225000 75000 83000 83000 50000 -1674000 -1624000 7232836 7000 36907000 -486000 -32951000 3477000 -7805000 -4437000 31000 28000 32000 31000 -1000 2000 46000 18000 2618000 350000 388000 9000 -5000 -359000 -218000 176000 -10000 311000 2000 -3984000 -3791000 184000 -170000 25000 12000 14000 172000 -209000 5035000 6094000 822000 5857000 6094000 -10000 44000 2035000 2138000 1774000 1466000 3809000 3604000 2618000 <p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zPwz0e3ZsSS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 1 - <span id="xdx_82E_zQz4kYHuG6b6">General</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">My Size, Inc. is developing unique measurement technologies based on algorithms with applications in a variety of areas, from the apparel e-commerce market, to the courier services market and to the Do It Yourself smartphone and tablet apps market. The technology is driven by proprietary algorithms which are able to calculate and record measurements in a variety of novel ways.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The Company has three subsidiaries, My Size Israel 2014 Ltd (“My Size Israel”) and Topspin Medical (Israel) Ltd., both of which are incorporated in Israel and My Size LLC which was incorporated in the Russian Federation. References to the Company include the subsidiaries unless the context indicates otherwise.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine month period ended September 30, 2021, the Company has incurred significant losses and negative cash flows from operations and has an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20210930_zektrCrZIvGj">42,476</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">. </span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The Company has financed its operations mainly through fundraising from various investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Taking into account the proceeds from warrant exercises and the Company’s financing in October 2021 described in note 7b below, management’s believes that cash on hand will be sufficient to meet its obligations for a period which is longer than 12 months. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Further to note 1b of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On May 26, 2021, the Company, My Size Israel and Shoshana Zigdon entered into an Amendment to Purchase Agreement (the “Amendment”) which made certain amendments to a Purchase Agreement between the parties dated February 16, 2014 (the “Purchase Agreement”). Pursuant to the Amendment, Ms. Zigdon agreed to irrevocably waive the right to repurchase certain assets related to the collection of data for measurement purposes that My Size Israel acquired from Ms. Zigdon under the Purchase Agreement and upon which the Company’s business is substantially dependent, and all past, present and future rights in any of the intellectual property rights sold, transferred and assigned to My Size Israel under the Purchase Agreement and any modifications, amendments or improvements made thereto, including, without limitation, any compensation, reward or any rights to royalties or to receive any payment or other consideration whatsoever in connection with such intellectual property rights (the “Waiver”). In consideration of the Waiver, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210525__20210526__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--ShoshanaZigdonMember_z3VKjZHOBzhk">2,500,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of common stock to Ms. Zigdon in a private placement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The Company measured the fair value of the shares based on the quoted market price of common stock adjusted to reflect the effect of the sales restrictions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine and three month period ended September 30, 2021, an amount of $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zhQRBbcQLQVj" title="Research and development expense">2,618</span> and $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zIjCOHY7PQq9" title="Research and development expense">0</span> was recorded in research and development expense respectively.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> -42476000 2500000 2618000 0 <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zoB6mM5G0FEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 2 - <span id="xdx_824_zobLnTKpQcoi">Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p id="xdx_845_ecustom--UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock_zHkM03hoWZij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a. </span> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><span>   <span id="xdx_866_zH39ozoAgSRa">Unaudited condensed consolidated financial statements</span></span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zhu6KuD0Mmxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b. </span> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><span>  <span id="xdx_86E_zfKJSW8A6K1k">Use of estimates</span></span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</p> <p id="xdx_845_ecustom--UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock_zHkM03hoWZij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a. </span> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><span>   <span id="xdx_866_zH39ozoAgSRa">Unaudited condensed consolidated financial statements</span></span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zhu6KuD0Mmxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b. </span> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><span>  <span id="xdx_86E_zfKJSW8A6K1k">Use of estimates</span></span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</p> <p id="xdx_80F_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zAGpRbVzLl3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 3 - <span id="xdx_82B_zGfBoc6egQ91">Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Fair value of financial instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company’s own credit risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In accordance with ASC 820 when measuring the fair value, an entity shall take into account the characteristics of the asset or liability if a market participant would take those characteristics into account when pricing the asset or liability at the measurement date. Such characteristics include, for example:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The condition and location of the asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Restrictions, if any, on the sale or the use of the asset.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.6in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Level 1 - </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Level 2 - </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Level 3 - </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The carrying amounts of cash and cash equivalents, accounts receivable, other receivables, trade payables and accounts payable approximate their fair value due to the short-term maturities of such instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The Company holds share certificates in iMine Corporation (“iMine”) formerly known as Diamante Minerals, Inc., a publicly-traded company on the OTCQB.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">Due to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.</span></p> <p id="xdx_89C_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zM6cVvJe7md3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> <span id="xdx_8BD_z4g0DzJhJA4g" style="display: none">Schedule of Fair value of Financial Assets and Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial assets</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; text-align: left">Investment in marketable securities (*)</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_fKCop_ztE4mZLwt2N6" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_fKCop_z48CTiUxv9gl" style="color: #000000; text-align: right" title="Investment in marketable securities">105</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_fKCop_zzKay3JcQERf" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>MY SIZE, INC. AND ITS SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Notes to Condensed Consolidated Interim Financial Statements (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>U.S. dollars in thousands (except share data and per share data)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 3 - Financial Instruments (Cont.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial assets</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4F_zlS0Po9v7Di" style="color: #000000; text-align: left">Investment in marketable securities (*)</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_fKCop_zf1KOvyQVi7i" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_fKCop_zqXz1QWS4N9l" style="color: #000000; text-align: right" title="Investment in marketable securities">59</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_fKCop_zosCc5qqxUy2" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_F0B_zoca2ZznZgdk" style="font: 10pt Times New Roman, Times, Serif; color: #000000">(*)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zkURB2lKQNM" style="font: 10pt Times New Roman, Times, Serif; color: #000000">For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $<span id="xdx_90A_eus-gaap--MarketableSecuritiesGainLoss_c20210101__20210930_pn3n3" title="Gain (loss) on marketable securities">46</span> and $<span id="xdx_900_eus-gaap--MarketableSecuritiesGainLoss_c20210701__20210930_pn3n3" title="Gain (loss) on marketable securities">24</span>, and $<span id="xdx_908_eus-gaap--MarketableSecuritiesGainLoss_c20200101__20200930_pn3n3" title="Gain (loss) on marketable securities">18</span> and $<span id="xdx_906_eus-gaap--MarketableSecuritiesGainLoss_c20200701__20200930_pn3n3" title="Gain (loss) on marketable securities">3</span>, respectively.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial liabilities</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000">Derivatives</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHqN5gG3kPog" style="color: #000000; text-align: right" title="Derivatives"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlU3KVVGjJLe" style="color: #000000; text-align: right" title="Derivatives">1</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPiHhvSe2pB1" style="color: #000000; text-align: right" title="Derivatives"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zGuY1uwx45I4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zM6cVvJe7md3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> <span id="xdx_8BD_z4g0DzJhJA4g" style="display: none">Schedule of Fair value of Financial Assets and Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial assets</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; text-align: left">Investment in marketable securities (*)</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_fKCop_ztE4mZLwt2N6" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_fKCop_z48CTiUxv9gl" style="color: #000000; text-align: right" title="Investment in marketable securities">105</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_fKCop_zzKay3JcQERf" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>MY SIZE, INC. AND ITS SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Notes to Condensed Consolidated Interim Financial Statements (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>U.S. dollars in thousands (except share data and per share data)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 3 - Financial Instruments (Cont.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial assets</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4F_zlS0Po9v7Di" style="color: #000000; text-align: left">Investment in marketable securities (*)</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_fKCop_zf1KOvyQVi7i" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_fKCop_zqXz1QWS4N9l" style="color: #000000; text-align: right" title="Investment in marketable securities">59</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_fKCop_zosCc5qqxUy2" style="color: #000000; text-align: right" title="Investment in marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_F0B_zoca2ZznZgdk" style="font: 10pt Times New Roman, Times, Serif; color: #000000">(*)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zkURB2lKQNM" style="font: 10pt Times New Roman, Times, Serif; color: #000000">For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $<span id="xdx_90A_eus-gaap--MarketableSecuritiesGainLoss_c20210101__20210930_pn3n3" title="Gain (loss) on marketable securities">46</span> and $<span id="xdx_900_eus-gaap--MarketableSecuritiesGainLoss_c20210701__20210930_pn3n3" title="Gain (loss) on marketable securities">24</span>, and $<span id="xdx_908_eus-gaap--MarketableSecuritiesGainLoss_c20200101__20200930_pn3n3" title="Gain (loss) on marketable securities">18</span> and $<span id="xdx_906_eus-gaap--MarketableSecuritiesGainLoss_c20200701__20200930_pn3n3" title="Gain (loss) on marketable securities">3</span>, respectively.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; color: #000000; text-align: left">Financial liabilities</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 14%; color: #000000; text-align: right"> </td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000">Derivatives</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHqN5gG3kPog" style="color: #000000; text-align: right" title="Derivatives"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlU3KVVGjJLe" style="color: #000000; text-align: right" title="Derivatives">1</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPiHhvSe2pB1" style="color: #000000; text-align: right" title="Derivatives"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></td><td style="color: #000000; text-align: left"> </td></tr> </table> 105000 59000 46000 24000 18000 3000 1000 <p id="xdx_802_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zALgL83vJUpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 4 - <span id="xdx_823_zQaLAGcTmdKj">Stock Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zVYeE2kfYVt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The stock-based expense equity awards recognized in the financial statements for services received is related to Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> <span id="xdx_8BD_zVXhAudK7ETj" style="display: none">Schedule of Stock Based Expenses</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt; color: #000000"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt; color: #000000"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; color: #000000; text-align: left">Stock-based compensation expense - Research and development</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zoTasZHy2mPc" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">103</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zsJGYL7QI4mj" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">126</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z1hOEmeBuTN2" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">33</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zViAluIClZ54" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">75</td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000; text-align: left">Stock-based compensation expense - Sales and marketing</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zX00khaACX58" style="color: #000000; text-align: right" title="Stock-based compensation expense">164</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zKiELf3ECs3e" style="color: #000000; text-align: right" title="Stock-based compensation expense">87</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zyfSMCPS3w5k" style="color: #000000; text-align: right" title="Stock-based compensation expense">71</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_znWilgoX4IG3" style="color: #000000; text-align: right" title="Stock-based compensation expense">41</td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; text-align: left; padding-bottom: 1.5pt">Stock-based compensation expense - General and administrative</td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_ze30ofPHfUj2" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">83</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zwcDgg5cCy8g" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">175</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zhxNHwxZdJkj" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">14</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zYvmCTMlm8Ng" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">109</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; padding-bottom: 2.5pt"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930_zhoj8y7MG3Ni" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">350</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930_zmPPssX1p1w3" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">388</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930_zgE73SQUHwMb" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">118</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930_zb47S70hII6g" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">225</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zEBfrF15fxB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Warrants issued to consultants:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In May 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed upon the three-month anniversary of the agreement to issue to the consultant a (i) a warrant to purchase up to <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_z5IPgCmBQ875">50,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of the Company’s common stock exercisable at $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zyGKccsOu0J8">1.50 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">per share and expiring on <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_ziDAMaAdho1i">December 31, 2022</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">, and (ii) a warrant to purchase up to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zn8qaxm8Sbia">50,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of the Company’s common stock exercisable at $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z7QobgHC0Jjj">2.00 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">per share and expiring on <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210531__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z1VrFbZ76Erb">December 31, 2022</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine and three month period ended September 30, 2021, an amount of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zaqj90skg7ma" title="Shares based compensation">63</span>, and $<span id="xdx_903_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zOQw0bHxjOn6" title="Shares based compensation">25</span>, respectively, was recorded by the Company as stock option compensation expense with respect to the consultant.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In June 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed to issue to the consultant a warrant to purchase up to <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zWDnw0Y5ulY">50,000</span> shares of the Company’s common stock exercisable at $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zVfcrmoVLJng">1.50</span> per share and expiring on <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z95tG5AwmJyh">December 31, 2022</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine and three month period ended September 30, 2021, an amount of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_z2zNO6pD8ldk">34</span> and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--ConsultantOneMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zqdVPsWMlBDb">25</span> was recorded by the Company as stock option compensation expense with respect to the consultant.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine month period ended September 30, 2021, the Company issued <span id="xdx_902_ecustom--WarrantsToConsultants_pid_c20210101__20210930_zI3d5XngtAXd" title="Warrants to consultants">150,000</span> warrants to consultants, no such warrants were exercised and warrants to purchase <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20210101__20210930_zKSM26g4t5L3" title="Number of options expired">3,667</span> shares expired.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded under sales and marketing was $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zf8HgqLkcAhi" title="Stock option compensation">116</span>, $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zlHb0WlP0B35" title="Stock option compensation">56</span>, $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_pn3n3" title="Stock option compensation">8</span> and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuVAcUuHKZ92" title="Stock option compensation">3</span> respectively and under general and administrative was $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zZcAdomB8Pod" title="Stock option compensation">0</span>, $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zPmsgHZMGIeb" title="Stock option compensation">0</span>, $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zf05zR5XCH7k" title="Stock option compensation">17</span> and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zWxAwpI461s1" title="Stock option compensation">5</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>MY SIZE, INC. AND ITS SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Notes to Condensed Consolidated Interim Financial Statements (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>U.S. dollars in thousands (except share data and per share data)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 4 - Stock Based Compensation (Cont.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Stock Option Plan for Employees:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In March 2017, the Company adopted the My Size, Inc. 2017 Equity Incentive Plan (the “2017 Employee Plan”) pursuant to which the Company’s Board of Directors may grant stock options to officers and key employees. The total number of options which may be granted to directors, officers, employees under this plan, was initially limited to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20170301__20170330__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMOA4WHfxLmi" title="Number of options granted">200,000</span> shares of common stock. Stock options can be granted with an exercise price equal to or less than the stock’s fair market value at the grant date. As further described below, in August 2020, the Company’s shareholders approved an increase in the number of shares available for issuance under the Plan to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20200810__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zztU6Rq8d4le" title="Number of shares available for issuance">1,450,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On May 25, 2020, the compensation committee of the Board of Directors of the Company reduced the exercise price of outstanding options of employees and directors of the Company for the purchase of an aggregate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20200524__20200525__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP1iqWWHIDz7">140,237 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of common stock of the Company (with exercise prices ranging between $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20200525__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zZK3IUCWPp1j">18.15 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">and $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20200525__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember_zky4RBahoXzl">9.15</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">) to $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20200525__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZU1GnSuNIBc">1.04 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">per share, which was the closing price for the Company’s common stock on May 22, 2020, and extended the term of the foregoing options for an additional one year from the original date of expiration. The incremental compensation cost resulting from the repricing was $<span id="xdx_901_ecustom--IncrementalCompensationCost_pn3n3_c20200524__20200525__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsNZw6k7Cdrk">53</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">, and the expenses during the nine and three month period ended September 30, 2021 were $<span id="xdx_907_ecustom--IncrementalCompensationExpenses_pn3n3_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPEZgzfMdN19">2 </span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90D_ecustom--IncrementalCompensationExpenses_pn3n3_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zS6CUMqESk76">1</span></span><span style="font: 10pt Times New Roman, Times, Serif">, respectively </span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">and the expenses during both the nine and three months ended September 30, 2020 were $<span id="xdx_90A_ecustom--IncrementalCompensationExpenses_pn3n3_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYgvQ0QPRFN">47 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">and $<span id="xdx_909_ecustom--IncrementalCompensationExpenses_pn3n3_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znWEeLk1GWU8">4</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On August 10, 2020, the Company’s shareholders approved an increase in the shares available for issuance under the 2017 Employee Plan from <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20200809__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zTROlNKDi30d" title="Number of shares available for issuance">200,000</span> to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20200810__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zREUkoebgF5c" title="Number of shares available for issuance">1,450,000</span> shares. As a result and pursuant to approval of the Company’s compensation committee that was contingent on the foregoing shareholder approval, the number of shares available for issuance under the Company’s 2017 Consultant Incentive Plan was reduced from <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20200809__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenConsultantIncentivePlanMember_zGHDIVOTWFE8" title="Number of shares available for issuance">466,667</span> to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20200810__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenConsultantIncentivePlanMember_zIkFKvu51Oa2" title="Number of shares available for issuance">216,667</span> shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">During the nine and three month period ended September 30, 2021, the Company granted an aggregate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_z7PcKdeIfT3f">97,500 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">of stock options under the 2017 Employee Plan, <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zZhNW6dZmNC4">4,458</span> options were exercised and options to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zixknDejUBph">40,777 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">and <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenEmployeePlanMember_zwwC5rmlNnic">19,167 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of common stock, respectively, expired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded was $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20210101__20210930_zJXvai39v0Ok" title="Stock option compensation">234</span> and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20210701__20210930_ziGf6sCMGhd2" title="Stock option compensation">62</span>, and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200101__20200930_z6oMsrW8Mff2" title="Stock option compensation">312</span> and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20200701__20200930_zUDr44d9UgV8" title="Stock option compensation">209</span>, respectively.</span></p> <p id="xdx_89B_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zVYeE2kfYVt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The stock-based expense equity awards recognized in the financial statements for services received is related to Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> <span id="xdx_8BD_zVXhAudK7ETj" style="display: none">Schedule of Stock Based Expenses</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Nine months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt; color: #000000"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Three months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>September 30,</b></span></p></td><td style="padding-bottom: 1.5pt; color: #000000"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000; text-align: center"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td><td style="color: #000000; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; color: #000000; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; color: #000000; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td><td style="color: #000000"> </td> <td colspan="2" style="color: #000000"> </td><td style="color: #000000"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; color: #000000; text-align: left">Stock-based compensation expense - Research and development</td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zoTasZHy2mPc" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">103</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zsJGYL7QI4mj" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">126</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z1hOEmeBuTN2" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">33</td><td style="width: 1%; color: #000000; text-align: left"> </td><td style="width: 2%; color: #000000"> </td> <td style="width: 1%; color: #000000; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zViAluIClZ54" style="width: 11%; color: #000000; text-align: right" title="Stock-based compensation expense">75</td><td style="width: 1%; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000; text-align: left">Stock-based compensation expense - Sales and marketing</td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zX00khaACX58" style="color: #000000; text-align: right" title="Stock-based compensation expense">164</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zKiELf3ECs3e" style="color: #000000; text-align: right" title="Stock-based compensation expense">87</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zyfSMCPS3w5k" style="color: #000000; text-align: right" title="Stock-based compensation expense">71</td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_znWilgoX4IG3" style="color: #000000; text-align: right" title="Stock-based compensation expense">41</td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; text-align: left; padding-bottom: 1.5pt">Stock-based compensation expense - General and administrative</td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_ze30ofPHfUj2" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">83</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zwcDgg5cCy8g" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">175</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zhxNHwxZdJkj" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">14</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; color: #000000; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zYvmCTMlm8Ng" style="border-bottom: Black 1.5pt solid; color: #000000; text-align: right" title="Stock-based compensation expense">109</td><td style="padding-bottom: 1.5pt; color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #000000"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td><td style="color: #000000"> </td> <td style="color: #000000; text-align: left"> </td><td style="color: #000000; text-align: right"> </td><td style="color: #000000; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #000000; padding-bottom: 2.5pt"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20210101__20210930_zhoj8y7MG3Ni" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">350</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20200101__20200930_zmPPssX1p1w3" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">388</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pn3n3_c20210701__20210930_zgE73SQUHwMb" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">118</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td><td style="color: #000000; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: #000000; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensation_pn3n3_c20200701__20200930_zb47S70hII6g" style="border-bottom: Black 2.5pt double; color: #000000; text-align: right" title="Stock-based compensation expense">225</td><td style="padding-bottom: 2.5pt; color: #000000; text-align: left"> </td></tr> </table> 103000 126000 33000 75000 164000 87000 71000 41000 83000 175000 14000 109000 350000 388000 118000 225000 50000 1.50 2022-12-31 50000 2.00 2022-12-31 63000 25000 50000 1.50 2022-12-31 34000 25000 150000 3667 116000 56000 8000 3000 0 0 17000 5000 200000 1450000 140237 18.15 9.15 1.04 53000 2000 1000 47000 4000 200000 1450000 466667 216667 97500 4458 40777 19167 234000 62000 312000 209000 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRhTcG0hMul6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 5 - <span id="xdx_821_zoRxY2zvwpEi">Contingencies and Commitments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On August 7, 2018, the Company commenced an action against North Empire LLC (“North Empire”) in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement (the “Agreement”) in which it is seeking damages in an amount to be determined at trial, but in no event less than $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20180806__20180807__dei--LegalEntityAxis__custom--NorthEmpireLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zd6tQmdorGgf">616,000</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">. On August 2, 2018, North Empire filed a Summons with Notice against the Company, also in the same Court, in which they allege damages in an amount of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_c20180801__20180802__dei--LegalEntityAxis__custom--NorthEmpireLLCMember_zgfz8a6AMULi">11.4 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">million arising from an alleged breach of the Agreement. On September 6, 2018 North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by the Company against them, alleging that the Company failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $<span id="xdx_909_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20180926__20180927__dei--LegalEntityAxis__custom--NorthEmpireLLCMember_z4Kbj7x9iPy3">10,958,589</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">. </span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">North Empire also filed a third-party complaint against the Company’s CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, the Company filed a reply to North Empire’s counterclaims. On November 15, 2018, the Company’s CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">The Company believes it is more likely than not that the counterclaims will be denied.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">On July 5, 2021, the Company was served with a legal complaint filed by Fidelity Venture Capital Ltd. and Dror Atzmon in the Magistrate’s Court in Tel Aviv for a monetary award in an amount of NIS <span id="xdx_908_eus-gaap--LossContingencyDamagesSoughtValue_pp0p0_uNIS_c20210704__20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zMs0vPOjyXs2">1,436,679 </span></span><span style="font: 10pt Times New Roman, Times, Serif">(approximately $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_uUSD_c20210704__20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zNNjekaGJWVb">450,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">) and a declaratory relief. The plaintiffs allege that the Company breached its contractual obligations to pay them for services allegedly rendered to the Company by the plaintiffs under a certain consulting agreement dated July 2, 2014, in an amount of NIS <span id="xdx_90D_eus-gaap--GainLossOnContractTermination_pp0p0_uNIS_c20210704__20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zOsKcvgwtqmd">819,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif">(approximately $<span id="xdx_90D_eus-gaap--GainLossOnContractTermination_pn3n3_uUSD_c20210704__20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zDzfzIZrMgm6">256,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">). </span><span style="font: 10pt Times New Roman, Times, Serif">Additionally, the plaintiffs allege that the Company should compensate them for losses allegedly incurred by them following their investment in the Company’s shares issued under a certain private offering. In the alternative, the plaintiffs move that the court will declare the investment agreement void with full restitution of plaintiffs’ original investment in an amount of NIS <span id="xdx_907_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pp0p0_uNIS_c20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zGiyVfgAnerb">1,329,650 </span></span><span style="font: 10pt Times New Roman, Times, Serif">(approximately $<span id="xdx_90D_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pn3n3_uUSD_c20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember__srt--TitleOfIndividualAxis__custom--MrDrorAtzmonMember_zYoV7yujK8cd">415,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">). </span><span id="xdx_901_eus-gaap--OtherCommitmentsDescription_c20210704__20210705__dei--LegalEntityAxis__custom--FidelityVentureCapitalLtdMember_zhcK2O5lHfJ">The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted the Company cannot evaluate the chances of the claim to succeed.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2021, the Company received notice from Custodian Ventures, LLC (“Custodian”) of its intention to nominate four candidates to stand for election to our board of directors at the Company’s 2021 annual meeting of stockholders. Custodian subsequently made a book and records request and has made public statements calling for changes to our management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> On September 22, 2021, Custodian commenced an action in the Court of Chancery of the State of Delaware captioned, Custodian Ventures, LLC v. MySize, Inc. (the “Delaware Action”). In the Delaware Action, Custodian sought an order from the Court of Chancery pursuant to Section 211 of the General Corporation Law of the State of Delaware compelling us to hold an annual meeting. On November 4, 2021, the Company entered into a settlement agreement (the “Settlement Agreement”) with Custodian and certain affiliates and director nominees (collectively, the “Lazar Parties”) settling and dismissing the Delaware Action (see note 7c).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 19, 2021, the Company commenced an action in the United States District Court for the Southern District of New York against Custodian, Activist Investing LLC, Milton C. Ault III, Ault Alpha LP, Ault Alpha GP LLC, Ault Capital Management LLC, Ault &amp; Company Inc., David Aboudi, Patrick Loney and David Nathan, , pursuant to Sections 13(d) and 14(a) of the Securities Exchange Act of 1934, and certain rules promulgated thereunder (the “SDNY Action”). The complaint sought, among other things, declaratory and injunctive relief related to defendants’ efforts to nominate a slate of directors for election at our next annual meeting. The complaint alleged that the defendants formed an undisclosed “group” for purposes of Section 13(d) and has misrepresented its true purpose in purchasing My Size, Inc. stock in filings made with the SEC. In addition, the complaint alleged that the defendants engaged in an unlawful solicitation of investors in violation of the Exchange Act proxy rules in connection with their efforts to elect a slate of directors to the Company’s board of directors. On October 20, 2021, the Court signed an order granting a hearing on an anticipated motion for a preliminary injunction and expedited scheduling and discovery in aid thereof, and scheduled that hearing for December 2, 2021. On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties settling and dismissing the claims asserted in the SDNY Action and the Delaware Action against one another (see note 7c). On November 8, 2021, the remaining defendants in the SDNY Action filed and answer and counterclaim asserting a claim against the Company pursuant to New York Civil Rights Law Section 70-a, also known as New York’s anti-SLAPP statute.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> 616000000 11400000 10958589000 1436679 450000000 819000 256000000 1329650 415000000 The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022. <p id="xdx_804_ecustom--SignificantEventsDuringReportingPeriodTextBlock_zmovGAPaUf73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 6 - <span id="xdx_82C_zGLPRiz2lLYi">Significant Events During the Reporting Period</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On January 8, 2021, the Company conducted a public offering of its securities pursuant to which it issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210107__20210108__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zwop9TKOTGqf" title="Stock issued during period, shares issue">1,569,179</span> shares of its common stock for gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20210107__20210108__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWALBKNDQAIf" title="Proceeds from common stock">2,008</span>. The net proceeds to the Company from the offering were approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20210107__20210108__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKBgMVBE8yHg" title="Net proceeds from from offering">1,700</span>, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In January and February 2021, a holder of warrants exercised warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210131_zcgM96GZZw15" title="Exercise of warrants"><span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210228_zb6xuq6iFMAj" title="Exercise of warrants">725,000</span></span> ordinary shares of the Company in exchange for $<span id="xdx_90D_ecustom--ExchangeOfOrdinaryShares_pn3n3_c20210101__20210131_zfoyybvvYXTl" title="Exchange of ordinary shares"><span id="xdx_905_ecustom--ExchangeOfOrdinaryShares_pn3n3_c20210101__20210228_zlQEibHEf4ye" title="Exchange of ordinary shares">797</span></span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On March 25, 2021, the Company conducted a public offering of its shares of common stock pursuant to which it issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210324__20210325__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z99vDwpEeCGc" title="Stock issued during period, shares issue">2,618,532</span> shares of its common stock for gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20210324__20210325__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHp04EewcIl9" title="Proceeds from common stock">3,300</span>. The net proceeds to the Company from the offering were approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20210324__20210325__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zB2ISY4Tw81a" title="Net proceeds from from offering">2,872</span>, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">d.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On May 7, 2021, the Company issued an additional <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210506__20210507__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjiC1CkoG5q5" title="Stock issued during period, shares issue">392,780</span> shares of the Company’s common stock in connection with the full exercise of the underwriter’s overallotment option granted in the Company’s March 2021 public offering. These additional shares were sold to the underwriter at a public offering price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210507__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMeXcnZyjDd3" title="Price per share">1.26</span> per share, resulting in additional net proceeds to the Company, net of the underwriting discount, of approximately $<span id="xdx_909_ecustom--UnderwritingDiscount_pn3n3_c20210506__20210507__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zITQgdtWCPW8" title="Underwriting discount">463</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">e.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On May 26, 2021, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210525__20210526__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--ShoshanaZigdonMember_z3ayqilzUTS" title="Stock issued during period, shares issue">2,500,000</span> shares of common stock to Ms. Zigdon in consideration of the Waiver. See note 1(c) above. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">f.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">In late 2019, a novel strain of COVID-19, also known as coronavirus, was reported in Wuhan, China. While initially the outbreak was largely concentrated in China, spread globally. Many countries around the world, including in Israel, have from time to time significant governmental measures being implemented to control the spread of the virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material limitations on the conduct of business. These measures have resulted in work stoppages and other disruptions. The Company has implemented remote working and work place protocols for its employees in accordance with government requirements. In addition, while the Company has seen an increased demand for MySizeID, the COVID-19 pandemic has had a particularly adverse impact on the retail industry and this has resulted in an adverse impact on the Company’s marketing and sales activities. For example, the Company has three ongoing pilots with international retailers that have been halted, the Company is unable to participate physically in industry conferences, its ability to meet with potential customers is limited and in certain instances sales processes have been delayed or cancelled. The extent to which COVID-19 continues to impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain COVID-19 or treat its impact.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"> </span></p> 1569179 2008000 1700000 725000 725000 797000 797000 2618532 3300000 2872000 392780 1.26 463000 2500000 <p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zRKcQ7aAu8b4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b>Note 7 - <span id="xdx_823_zw2i9VSs4lQ8">Events Subsequent to the balance sheet date</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On October 26, 2021, holders of warrants exercised an aggregate of <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zIuQgW3k3XR9" title="Exercise of warrants, shares">2,625,908</span> shares of common stock in consideration for $<span id="xdx_90E_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pn3n3_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--HoldersMember_z1Saa51Tnofh" title="Exercise of warrants">2,889</span>.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">On October 28, 2021, the Company sold in a registered direct offering <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zegYFDKaKKji">2,514,800 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of its common stock and, in a concurrent private placement, an aggregate of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zioDv65VlVtl">1,886,100 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">unregistered warrants to purchase shares of common stock, at an offering price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEZAspf93Ibe">1.352 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">per share and associated warrant. In addition, on the same day, the Company sold in a private placement <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6OmZHzOlZgh">3,772,208 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">unregistered shares of common stock and unregistered warrants to purchase up to an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zSNulee7zaH">2,829,156 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">shares of common stock at the same purchase price as in the registered direct offering. The warrants are immediately exercisable and will expire <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zR4MlAUfdzA8" title="Warrant expiration term::XDX::5"><span style="-sec-ix-hidden: xdx2ixbrl0737">five years</span></span> from issuance at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_dt_c20211028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3hT7UG2LAXk" title="Warrant exercise price per share">1.26</span> per share, subject to adjustment as set forth therein.The gross proceeds from the offerings were $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEkXRO0X3VJd">8,500</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">. The net proceeds to the Company from the offerings were approximately $<span id="xdx_90E_ecustom--NetProceedsFromIssuancePublicOffering_pn3n3_c20211025__20211026__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zm7dQjaCt8j">7,560</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: #000000">, after deducting placement agent’s fees and other estimated offering expenses payable by the Company. In connection with the offerings, the Company issued to the placement agent warrants to purchase <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20211028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcfFNZ1eTmYd" title="Warrants to purchase shares">440,091</span> shares on substantially the same terms as the purchasers in the offerings at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6tin2ce5TEk" title="Warrant exercise price per share">1.69</span> per share and a term expiring on <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20211028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsL7GugaFZT7" title="Warrant expiring date">October 26, 2026</span>.</span> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <span style="font: 10pt Times New Roman, Times, Serif; color: #000000"/></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"/></tr> <tr style="vertical-align: top"> <td> </td> <td>c.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties. Pursuant to the Settlement Agreement, the Company and the Lazar Parties agreed to compromise and settle the Delaware Action and SDNY Action. In addition, pursuant to the Settlement Agreement, the Company agreed to reimburse Custodian for out of pocket expenses and in consideration for the dismissal and release of claims against the Company an aggregate amount equal to $<span id="xdx_901_eus-gaap--LitigationSettlementAmountAwardedToOtherParty_pn3n3_c20211103__20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zGW93nHVTHog" title="Claim amount paid">275</span>, to be paid within three business days of the effective date of the Settlement Agreement. With respect to the Company’s 2021 annual meeting of stockholders, Custodian agreed to, among other things, withdraw or rescind (i) its May 12, 2021 notice of stockholder nominations of four director candidates with respect to the Company’s 2021 annual meeting of stockholders, (ii) the notice dated October 28, 2021 submitted by Custodian to the Company notifying the Company of Custodian’s continued intent to bring its nomination of four director candidates before the Company’s stockholders at the 2021 annual meeting, and (iii) any and all related materials and notices submitted to the Company in connection therewith or related thereto and to not take any further action in connection with the solicitation of any proxies in connection with the Company. Custodian also agreed to cease any and all solicitation and other activities in connection with the 2021 annual meeting. In addition, Custodian agreed to certain customary standstill provisions for a period of five years beginning on the effective date of the Agreement (the “Standstill Period”). The Settlement Agreement also provides that during the Standstill Period, the Lazar Parties will vote all shares of common stock of the Company it beneficially owns in in accordance with any proposal or recommendation made by the Company or the Board of Directors of the Company that is submitted to the stockholders of the Company, unless to do so would violate applicable law and except with respect to certain extraordinary transactions. The Settlement Agreement also contains non-disparagement and confidentiality provisions, subject to certain exceptions.</span></td></tr> </table> 2625908 2889000 2514800 1886100 1.352 3772208 2829156 1.26 8500000 7560000 440091 1.69 2026-10-26 275000 Represents an amount less than $1 See note 1 c. Represents an amount less than $1 Represents an amount less than $1 For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $46 and $24, and $18 and $3, respectively. XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
 9 Months Ended
Sep. 30, 2021
Nov. 10, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2021  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 001-37370  
Entity Registrant Name MY SIZE, INC.  
Entity Central Index Key 0001211805  
Entity Tax Identification Number 51-0394637  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One HaYarden 4  
Entity Address, Address Line Two POB 1026  
Entity Address, City or Town Airport City  
Entity Address, Country IL  
Entity Address, Postal Zip Code 7010000  
City Area Code +972  
Local Phone Number 3-600-9030  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol MYSZ  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   23,982,503
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 3,539 $ 1,689
Restricted cash 270 85
Restricted deposit 184
Accounts receivable 37 28
Other receivables and prepaid expenses 121 482
Total current assets 3,967 2,468
Property and equipment, net 108 128
Right-of-use asset 792 911
Investment in marketable securities 105 59
Total non-current assets 1,005 1,098
Total assets 4,972 3,566
Current liabilities:    
Operating lease liability 130 129
Trade payables 556 381
Accounts payable 705 400
Derivatives [1] 1
Total current liabilities 1,391 911
Operating lease liability 493 579
Total non-current liabilities 493 579
Total liabilities 1,884 1,490
COMMITMENTS AND CONTINGENCIES  
Stock Capital -    
Common stock of $0.001 par value - Authorized: 100,000,000 shares; Issued and outstanding: 15,069,587 and 7,232,836 as of September 30, 2021 and December 31, 2020, respectively 15 7
Additional paid-in capital 45,981 37,164
Accumulated other comprehensive loss (432) (424)
Accumulated deficit (42,476) (34,671)
Total stockholders’ equity 3,088 2,076
Total liabilities and stockholders’ equity $ 4,972 $ 3,566
[1] Represents an amount less than $1
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 15,069,587 7,232,836
Common stock, shares outstanding 15,069,587 7,232,836
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]        
Revenues $ 31 $ 88 $ 88 $ 139
Cost of revenues (1) (2)
Gross profit 31 87 88 137
Operating expenses        
Research and development (462) (397) (3,842) (1,085)
Sales and marketing (521) (555) (1,798) (1,632)
General and administrative (1,074) (777) (2,303) (1,855)
Total operating expenses (2,507) (1,729) (7,943) (4,572)
Operating loss (2,026) (1,642) (7,855) (4,435)
Financial income (expenses), net 18 (32) 50 (2)
Net loss (2,008) (1,674) (7,805) (4,437)
Other comprehensive income (loss):        
Foreign currency translation differences 8 50 (8) 53
Total comprehensive loss $ (2,000) $ (1,624) $ (7,813) $ (4,384)
Basic and diluted loss per share $ (0.13) $ (0.23) $ (0.62) $ (0.89)
Basic and diluted weighted average number of shares outstanding 15,044,184 7,217,619 12,546,022 4,971,202
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 2 $ 30,102 $ (539) $ (28,514) $ 1,051
Beginning balance, shares at Dec. 31, 2019 2,085,900        
Stock-based compensation related to options granted to employees and consultants 388 388
Issuance of shares, net of issuance cost of $1,000 $ 3 5,992 5,995
Issuance of shares, net of issuance cost of $1,000, shares 2,439,802        
Exercise of warrants and pre funded warrants $ 2 97     99
Exercise of warrants and pre funded warrants, shares 2,707,134        
Liability reclassified to equity 328 328
Total comprehensive loss 53 (4,437) (4,384)
Ending balance, value at Sep. 30, 2020 $ 7 36,907 (486) (32,951) 3,477
Ending balance, shares at Sep. 30, 2020 7,232,836        
Beginning balance, value at Jun. 30, 2020 $ 7 36,599 (536) (31,277) 4,793
Beginning balance, shares at Jun. 30, 2020 7,157,836        
Stock-based compensation related to options granted to employees and consultants 225 225
Exercise of warrants [1] 83 83
Exercise of warrants, shares 75,000        
Total comprehensive loss 50 (1,674) (1,624)
Ending balance, value at Sep. 30, 2020 $ 7 36,907 (486) (32,951) 3,477
Ending balance, shares at Sep. 30, 2020 7,232,836        
Beginning balance, value at Dec. 31, 2020 $ 7 37,164 (424) (34,671) 2,076
Beginning balance, shares at Dec. 31, 2020 7,232,836        
Stock-based compensation related to options granted to employees and consultants 350 350
Exercise of options granted to employees      
Exercise of options granted to employees, shares 4,458        
Restricted shares issued to shareholder (*) [2] $ 3 2,615 2,618
Restricted shares issued to shareholde, shares 2,500,000        
Issuance of shares, net of issuance cost of $1,000 $ 4 5,031 5,035
Issuance of shares, net of issuance cost of $1,000, shares 4,580,491        
Exercise of warrants $ 1 821 822
Exercise of warrants, shares 751,802        
Total comprehensive loss (8) (7,805) (7,813)
Ending balance, value at Sep. 30, 2021 $ 15 45,981 (432) (42,476) 3,088
Ending balance, shares at Sep. 30, 2021 15,069,587        
Beginning balance, value at Jun. 30, 2021 $ 15 45,838 (440) (40,468) 4,945
Beginning balance, shares at Jun. 30, 2021 15,038,327        
Stock-based compensation related to options granted to employees and consultants 118 118
Exercise of options granted to employees [3] [3] [3]
Exercise of warrants [3] 25 25
Exercise of warrants, shares 26,802        
Total comprehensive loss 8 (2,008) (2,000)
Ending balance, value at Sep. 30, 2021 $ 15 $ 45,981 $ (432) $ (42,476) $ 3,088
Ending balance, shares at Sep. 30, 2021 15,069,587        
[1] Represents an amount less than $1
[2] See note 1 c.
[3] Represents an amount less than $1
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Statement of Stockholders' Equity [Abstract]    
Issuance cost, net $ 768 $ 1,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (7,805) $ (4,437)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 31 28
Amortization of operating lease right-of-use asset 32 31
Revaluation of warrants and derivatives (1) 2
Revaluation of investment in marketable securities (46) (18)
Expense arising from restricted shares issued to compensate waiver by a shareholder 2,618
Stock based compensation 350 388
(Increase) decrease in accounts receivables (9) 5
Decrease in other receivables and prepaid expenses 359 218
Increase (decrease) in trade payable 176 (10)
Increase in accounts payable 311 2
Net cash used in operating activities (3,984) (3,791)
Cash flows from investing activities:    
Change in restricted deposits 184 (170)
Investment in right-of-use asset (25)
Purchase of property and equipment (12) (14)
Net cash provided by (used in) investing activities 172 (209)
Cash flows from financing activities:    
Proceeds from issuance of shares, net of issuance costs 5,035 6,094
Proceeds from Exercise of warrants 822
Net cash provided by financing activities 5,857 6,094
Effect of exchange rate fluctuations on cash and cash equivalents (10) 44
Increase in cash, cash equivalents and restricted cash 2,035 2,138
Cash, cash equivalents and restricted cash at the beginning of the period 1,774 1,466
Cash, cash equivalents and restricted cash at the end of the period 3,809 3,604
Non cash activities:    
Restricted shares issued to shareholder $ 2,618
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
General
 9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General

Note 1 - General

 

  a.

My Size, Inc. is developing unique measurement technologies based on algorithms with applications in a variety of areas, from the apparel e-commerce market, to the courier services market and to the Do It Yourself smartphone and tablet apps market. The technology is driven by proprietary algorithms which are able to calculate and record measurements in a variety of novel ways.

 

The Company has three subsidiaries, My Size Israel 2014 Ltd (“My Size Israel”) and Topspin Medical (Israel) Ltd., both of which are incorporated in Israel and My Size LLC which was incorporated in the Russian Federation. References to the Company include the subsidiaries unless the context indicates otherwise.

     
  b.

During the nine month period ended September 30, 2021, the Company has incurred significant losses and negative cash flows from operations and has an accumulated deficit of $42,476. The Company has financed its operations mainly through fundraising from various investors.

 

Taking into account the proceeds from warrant exercises and the Company’s financing in October 2021 described in note 7b below, management’s believes that cash on hand will be sufficient to meet its obligations for a period which is longer than 12 months. 

     
  c.

Further to note 1b of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020:

 

On May 26, 2021, the Company, My Size Israel and Shoshana Zigdon entered into an Amendment to Purchase Agreement (the “Amendment”) which made certain amendments to a Purchase Agreement between the parties dated February 16, 2014 (the “Purchase Agreement”). Pursuant to the Amendment, Ms. Zigdon agreed to irrevocably waive the right to repurchase certain assets related to the collection of data for measurement purposes that My Size Israel acquired from Ms. Zigdon under the Purchase Agreement and upon which the Company’s business is substantially dependent, and all past, present and future rights in any of the intellectual property rights sold, transferred and assigned to My Size Israel under the Purchase Agreement and any modifications, amendments or improvements made thereto, including, without limitation, any compensation, reward or any rights to royalties or to receive any payment or other consideration whatsoever in connection with such intellectual property rights (the “Waiver”). In consideration of the Waiver, the Company issued 2,500,000 shares of common stock to Ms. Zigdon in a private placement.

 

The Company measured the fair value of the shares based on the quoted market price of common stock adjusted to reflect the effect of the sales restrictions.

 

During the nine and three month period ended September 30, 2021, an amount of $2,618 and $0 was recorded in research and development expense respectively.

 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies

Note 2 - Significant Accounting Policies

 

a.    Unaudited condensed consolidated financial statements:

 

The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2021.

   

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2020.

 

b.   Use of estimates:

 

The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments
 9 Months Ended
Sep. 30, 2021
Investments, All Other Investments [Abstract]  
Financial Instruments

Note 3 - Financial Instruments

 

Fair value of financial instruments:

 

Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company’s own credit risk.

 

In accordance with ASC 820 when measuring the fair value, an entity shall take into account the characteristics of the asset or liability if a market participant would take those characteristics into account when pricing the asset or liability at the measurement date. Such characteristics include, for example:

 

  a. The condition and location of the asset.
     
  b. Restrictions, if any, on the sale or the use of the asset.

 

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

  Level 1 - Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
     
  Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
     
  Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

 

The carrying amounts of cash and cash equivalents, accounts receivable, other receivables, trade payables and accounts payable approximate their fair value due to the short-term maturities of such instruments.

 

The Company holds share certificates in iMine Corporation (“iMine”) formerly known as Diamante Minerals, Inc., a publicly-traded company on the OTCQB.

 

Due to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.

 

   September 30, 2021 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    105    - 

 

 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments (Cont.)

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    59    - 

 

(*) For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $46 and $24, and $18 and $3, respectively.

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial liabilities               
                
Derivatives   -    1    - 

 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock Based Compensation

Note 4 - Stock Based Compensation

 

The stock-based expense equity awards recognized in the financial statements for services received is related to Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:

 

  

Nine months ended

September 30,

  

Three months ended

September 30,

 
   2021   2020   2021   2020 
                 
Stock-based compensation expense - Research and development   103    126    33    75 
Stock-based compensation expense - Sales and marketing   164    87    71    41 
Stock-based compensation expense - General and administrative   83    175    14    109 
                     
    350    388    118    225 

 

Warrants issued to consultants:

 

  a.

In May 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed upon the three-month anniversary of the agreement to issue to the consultant a (i) a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $1.50 per share and expiring on December 31, 2022, and (ii) a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $2.00 per share and expiring on December 31, 2022.

 

During the nine and three month period ended September 30, 2021, an amount of $63, and $25, respectively, was recorded by the Company as stock option compensation expense with respect to the consultant.

     

 

 

 b.

In June 2021, the Company entered into a consulting agreement with a consultant pursuant to which the Company agreed to issue to the consultant a warrant to purchase up to 50,000 shares of the Company’s common stock exercisable at $1.50 per share and expiring on December 31, 2022.

 

During the nine and three month period ended September 30, 2021, an amount of $34 and $25 was recorded by the Company as stock option compensation expense with respect to the consultant.

     
  c. During the nine month period ended September 30, 2021, the Company issued 150,000 warrants to consultants, no such warrants were exercised and warrants to purchase 3,667 shares expired.

 

The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded under sales and marketing was $116, $56, $8 and $3 respectively and under general and administrative was $0, $0, $17 and $5, respectively.

 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 4 - Stock Based Compensation (Cont.)

 

Stock Option Plan for Employees:

 

In March 2017, the Company adopted the My Size, Inc. 2017 Equity Incentive Plan (the “2017 Employee Plan”) pursuant to which the Company’s Board of Directors may grant stock options to officers and key employees. The total number of options which may be granted to directors, officers, employees under this plan, was initially limited to 200,000 shares of common stock. Stock options can be granted with an exercise price equal to or less than the stock’s fair market value at the grant date. As further described below, in August 2020, the Company’s shareholders approved an increase in the number of shares available for issuance under the Plan to 1,450,000.

 

On May 25, 2020, the compensation committee of the Board of Directors of the Company reduced the exercise price of outstanding options of employees and directors of the Company for the purchase of an aggregate of 140,237 shares of common stock of the Company (with exercise prices ranging between $18.15 and $9.15) to $1.04 per share, which was the closing price for the Company’s common stock on May 22, 2020, and extended the term of the foregoing options for an additional one year from the original date of expiration. The incremental compensation cost resulting from the repricing was $53, and the expenses during the nine and three month period ended September 30, 2021 were $2 and $1, respectively and the expenses during both the nine and three months ended September 30, 2020 were $47 and $4, respectively.

 

On August 10, 2020, the Company’s shareholders approved an increase in the shares available for issuance under the 2017 Employee Plan from 200,000 to 1,450,000 shares. As a result and pursuant to approval of the Company’s compensation committee that was contingent on the foregoing shareholder approval, the number of shares available for issuance under the Company’s 2017 Consultant Incentive Plan was reduced from 466,667 to 216,667 shares.

 

During the nine and three month period ended September 30, 2021, the Company granted an aggregate of 97,500 of stock options under the 2017 Employee Plan, 4,458 options were exercised and options to purchase 40,777 and 19,167 shares of common stock, respectively, expired.

 

The total stock option compensation expense during the nine and three month period ended September 30, 2021 and 2020 which was recorded was $234 and $62, and $312 and $209, respectively.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Contingencies and Commitments
 9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Contingencies and Commitments

Note 5 - Contingencies and Commitments

 

  a.

On August 7, 2018, the Company commenced an action against North Empire LLC (“North Empire”) in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement (the “Agreement”) in which it is seeking damages in an amount to be determined at trial, but in no event less than $616,000. On August 2, 2018, North Empire filed a Summons with Notice against the Company, also in the same Court, in which they allege damages in an amount of $11.4 million arising from an alleged breach of the Agreement. On September 6, 2018 North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by the Company against them, alleging that the Company failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958,589. North Empire also filed a third-party complaint against the Company’s CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, the Company filed a reply to North Empire’s counterclaims. On November 15, 2018, the Company’s CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims.

 

The Company believes it is more likely than not that the counterclaims will be denied.

     
  b.

On July 5, 2021, the Company was served with a legal complaint filed by Fidelity Venture Capital Ltd. and Dror Atzmon in the Magistrate’s Court in Tel Aviv for a monetary award in an amount of NIS 1,436,679 (approximately $450,000) and a declaratory relief. The plaintiffs allege that the Company breached its contractual obligations to pay them for services allegedly rendered to the Company by the plaintiffs under a certain consulting agreement dated July 2, 2014, in an amount of NIS 819,000 (approximately $256,000). Additionally, the plaintiffs allege that the Company should compensate them for losses allegedly incurred by them following their investment in the Company’s shares issued under a certain private offering. In the alternative, the plaintiffs move that the court will declare the investment agreement void with full restitution of plaintiffs’ original investment in an amount of NIS 1,329,650 (approximately $415,000). The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022.

 

At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted the Company cannot evaluate the chances of the claim to succeed.

     
  c.

In May 2021, the Company received notice from Custodian Ventures, LLC (“Custodian”) of its intention to nominate four candidates to stand for election to our board of directors at the Company’s 2021 annual meeting of stockholders. Custodian subsequently made a book and records request and has made public statements calling for changes to our management.

 

 On September 22, 2021, Custodian commenced an action in the Court of Chancery of the State of Delaware captioned, Custodian Ventures, LLC v. MySize, Inc. (the “Delaware Action”). In the Delaware Action, Custodian sought an order from the Court of Chancery pursuant to Section 211 of the General Corporation Law of the State of Delaware compelling us to hold an annual meeting. On November 4, 2021, the Company entered into a settlement agreement (the “Settlement Agreement”) with Custodian and certain affiliates and director nominees (collectively, the “Lazar Parties”) settling and dismissing the Delaware Action (see note 7c).

 

On October 19, 2021, the Company commenced an action in the United States District Court for the Southern District of New York against Custodian, Activist Investing LLC, Milton C. Ault III, Ault Alpha LP, Ault Alpha GP LLC, Ault Capital Management LLC, Ault & Company Inc., David Aboudi, Patrick Loney and David Nathan, , pursuant to Sections 13(d) and 14(a) of the Securities Exchange Act of 1934, and certain rules promulgated thereunder (the “SDNY Action”). The complaint sought, among other things, declaratory and injunctive relief related to defendants’ efforts to nominate a slate of directors for election at our next annual meeting. The complaint alleged that the defendants formed an undisclosed “group” for purposes of Section 13(d) and has misrepresented its true purpose in purchasing My Size, Inc. stock in filings made with the SEC. In addition, the complaint alleged that the defendants engaged in an unlawful solicitation of investors in violation of the Exchange Act proxy rules in connection with their efforts to elect a slate of directors to the Company’s board of directors. On October 20, 2021, the Court signed an order granting a hearing on an anticipated motion for a preliminary injunction and expedited scheduling and discovery in aid thereof, and scheduled that hearing for December 2, 2021. On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties settling and dismissing the claims asserted in the SDNY Action and the Delaware Action against one another (see note 7c). On November 8, 2021, the remaining defendants in the SDNY Action filed and answer and counterclaim asserting a claim against the Company pursuant to New York Civil Rights Law Section 70-a, also known as New York’s anti-SLAPP statute.

 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Events During the Reporting Period
 9 Months Ended
Sep. 30, 2021
Significant Events During Reporting Period  
Significant Events During the Reporting Period

Note 6 - Significant Events During the Reporting Period

 

  a. On January 8, 2021, the Company conducted a public offering of its securities pursuant to which it issued 1,569,179 shares of its common stock for gross proceeds of $2,008. The net proceeds to the Company from the offering were approximately $1,700, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.
     
  b. In January and February 2021, a holder of warrants exercised warrants to purchase 725,000 ordinary shares of the Company in exchange for $797.
     
  c. On March 25, 2021, the Company conducted a public offering of its shares of common stock pursuant to which it issued 2,618,532 shares of its common stock for gross proceeds of $3,300. The net proceeds to the Company from the offering were approximately $2,872, after deducting placement agent’s fees and other estimated offering expenses payable by the Company.
     
  d. On May 7, 2021, the Company issued an additional 392,780 shares of the Company’s common stock in connection with the full exercise of the underwriter’s overallotment option granted in the Company’s March 2021 public offering. These additional shares were sold to the underwriter at a public offering price of $1.26 per share, resulting in additional net proceeds to the Company, net of the underwriting discount, of approximately $463.
     
  e. On May 26, 2021, the Company issued 2,500,000 shares of common stock to Ms. Zigdon in consideration of the Waiver. See note 1(c) above.
     
  f. In late 2019, a novel strain of COVID-19, also known as coronavirus, was reported in Wuhan, China. While initially the outbreak was largely concentrated in China, spread globally. Many countries around the world, including in Israel, have from time to time significant governmental measures being implemented to control the spread of the virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material limitations on the conduct of business. These measures have resulted in work stoppages and other disruptions. The Company has implemented remote working and work place protocols for its employees in accordance with government requirements. In addition, while the Company has seen an increased demand for MySizeID, the COVID-19 pandemic has had a particularly adverse impact on the retail industry and this has resulted in an adverse impact on the Company’s marketing and sales activities. For example, the Company has three ongoing pilots with international retailers that have been halted, the Company is unable to participate physically in industry conferences, its ability to meet with potential customers is limited and in certain instances sales processes have been delayed or cancelled. The extent to which COVID-19 continues to impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain COVID-19 or treat its impact.

 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Events Subsequent to the balance sheet date
 9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Events Subsequent to the balance sheet date

Note 7 - Events Subsequent to the balance sheet date

 

  a. On October 26, 2021, holders of warrants exercised an aggregate of 2,625,908 shares of common stock in consideration for $2,889.
     
  b. On October 28, 2021, the Company sold in a registered direct offering 2,514,800 shares of its common stock and, in a concurrent private placement, an aggregate of 1,886,100 unregistered warrants to purchase shares of common stock, at an offering price of $1.352 per share and associated warrant. In addition, on the same day, the Company sold in a private placement 3,772,208 unregistered shares of common stock and unregistered warrants to purchase up to an aggregate of 2,829,156 shares of common stock at the same purchase price as in the registered direct offering. The warrants are immediately exercisable and will expire five years from issuance at an exercise price of $1.26 per share, subject to adjustment as set forth therein.The gross proceeds from the offerings were $8,500. The net proceeds to the Company from the offerings were approximately $7,560, after deducting placement agent’s fees and other estimated offering expenses payable by the Company. In connection with the offerings, the Company issued to the placement agent warrants to purchase 440,091 shares on substantially the same terms as the purchasers in the offerings at an exercise price of $1.69 per share and a term expiring on October 26, 2026.

 

   
  c. On November 4, 2021, the Company entered into the Settlement Agreement with the Lazar Parties. Pursuant to the Settlement Agreement, the Company and the Lazar Parties agreed to compromise and settle the Delaware Action and SDNY Action. In addition, pursuant to the Settlement Agreement, the Company agreed to reimburse Custodian for out of pocket expenses and in consideration for the dismissal and release of claims against the Company an aggregate amount equal to $275, to be paid within three business days of the effective date of the Settlement Agreement. With respect to the Company’s 2021 annual meeting of stockholders, Custodian agreed to, among other things, withdraw or rescind (i) its May 12, 2021 notice of stockholder nominations of four director candidates with respect to the Company’s 2021 annual meeting of stockholders, (ii) the notice dated October 28, 2021 submitted by Custodian to the Company notifying the Company of Custodian’s continued intent to bring its nomination of four director candidates before the Company’s stockholders at the 2021 annual meeting, and (iii) any and all related materials and notices submitted to the Company in connection therewith or related thereto and to not take any further action in connection with the solicitation of any proxies in connection with the Company. Custodian also agreed to cease any and all solicitation and other activities in connection with the 2021 annual meeting. In addition, Custodian agreed to certain customary standstill provisions for a period of five years beginning on the effective date of the Agreement (the “Standstill Period”). The Settlement Agreement also provides that during the Standstill Period, the Lazar Parties will vote all shares of common stock of the Company it beneficially owns in in accordance with any proposal or recommendation made by the Company or the Board of Directors of the Company that is submitted to the stockholders of the Company, unless to do so would violate applicable law and except with respect to certain extraordinary transactions. The Settlement Agreement also contains non-disparagement and confidentiality provisions, subject to certain exceptions.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Unaudited condensed consolidated financial statements

a.    Unaudited condensed consolidated financial statements:

 

The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2021.

   

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2020.

 
Use of estimates

b.   Use of estimates:

 

The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments (Tables)
 9 Months Ended
Sep. 30, 2021
Investments, All Other Investments [Abstract]  
Schedule of Fair value of Financial Assets and Liabilities

 

   September 30, 2021 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    105    - 

 

 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments (Cont.)

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities (*)   -    59    - 

 

(*) For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $46 and $24, and $18 and $3, respectively.

 

   December 31, 2020 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial liabilities               
                
Derivatives   -    1    - 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Based Expenses

The stock-based expense equity awards recognized in the financial statements for services received is related to Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:

 

  

Nine months ended

September 30,

  

Three months ended

September 30,

 
   2021   2020   2021   2020 
                 
Stock-based compensation expense - Research and development   103    126    33    75 
Stock-based compensation expense - Sales and marketing   164    87    71    41 
Stock-based compensation expense - General and administrative   83    175    14    109 
                     
    350    388    118    225 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
General (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
May 26, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]            
Retained Earnings (Accumulated Deficit)   $ 42,476   $ 42,476   $ 34,671
Research and development expense   462 $ 397 3,842 $ 1,085  
Research and Development Expense [Member]            
Subsidiary, Sale of Stock [Line Items]            
Research and development expense   $ 0   $ 2,618    
Private Placement [Member] | ShoshanaZigdon [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock Issued During Period, Shares, New Issues 2,500,000          
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Fair value of Financial Assets and Liabilities (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]          
Gain (loss) on marketable securities $ 24 $ 3 $ 46 $ 18  
Fair Value, Inputs, Level 1 [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Investment in marketable securities [1]    
Derivatives        
Fair Value, Inputs, Level 2 [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Investment in marketable securities [1] 105   105   59
Derivatives         1
Fair Value, Inputs, Level 3 [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Investment in marketable securities [1]    
Derivatives        
[1] For the nine and three month periods ended September 30, 2021 and 2020, the recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $46 and $24, and $18 and $3, respectively.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Stock Based Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 118 $ 225 $ 350 $ 388
Research and Development Expense [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 33 75 103 126
Selling and Marketing Expense [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 71 41 164 87
General and Administrative Expense [Member]        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 14 $ 109 $ 83 $ 175
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
May 25, 2020
Mar. 30, 2017
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
May 31, 2021
Feb. 28, 2021
Jan. 31, 2021
Aug. 10, 2020
Aug. 09, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                 725,000 725,000    
Shares based compensation     $ 118 $ 225 $ 350 $ 388            
Warrants to consultants         150,000              
Number of options expired         3,667              
Stock option compensation     $ 62 209 $ 234 312            
Two Thousand Seventeen Employee Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of options expired     19,167   40,777              
Number of options granted         97,500              
Number of shares available for issuance                     1,450,000 200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period         4,458              
Two Thousand Seventeen Employee Plan [Member] | Common Stock [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of options granted 140,237 200,000                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 1.04                      
Incremental compensation cost $ 53                      
[custom:IncrementalCompensationExpenses]     $ 1 4 $ 2 47            
Two Thousand Seventeen Employee Plan [Member] | Common Stock [Member] | Minimum [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 18.15                      
Two Thousand Seventeen Employee Plan [Member] | Common Stock [Member] | Maximum [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 9.15                      
Two Thousand Seventeen Consultant Incentive Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares available for issuance                     216,667 466,667
Selling and Marketing Expense [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares based compensation     71 41 164 87            
Stock option compensation     8 3 116 56            
General and Administrative Expense [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares based compensation     14 109 83 175            
Stock option compensation     17 $ 5 0 $ 0            
Consulting Agreement [Member] | Consultant [Member] | Warrant One [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             50,000 50,000        
Consulting Agreement [Member] | Consultant One [Member] | Warrant One [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Exercise Price of Warrants or Rights             $ 1.50 $ 1.50        
Warrants and Rights Outstanding, Maturity Date               Dec. 31, 2022        
Shares based compensation     25   34              
Consulting Agreement [Member] | Consultant One [Member] | Warrant Two [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights               50,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 2.00        
Warrants and Rights Outstanding, Maturity Date             Dec. 31, 2022 Dec. 31, 2022        
Consulting Agreement [Member] | Consultant One [Member] | Warrant [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares based compensation     $ 25   $ 63              
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Contingencies and Commitments (Details Narrative)
$ in Thousands
Jul. 05, 2021
USD ($)
Jul. 05, 2021
ILS (₪)
Sep. 27, 2018
USD ($)
Aug. 07, 2018
USD ($)
Aug. 02, 2018
USD ($)
Jul. 05, 2021
ILS (₪)
North Empire L L C [Member]            
Loss Contingency, Damages Sought, Value     $ 10,958,589   $ 11,400  
North Empire L L C [Member] | Securities Purchase Agreement [Member]            
Loss Contingency, Damages Sought, Value       $ 616,000    
Fidelity Venture Capital Ltd [Member]            
Other Commitments, Description The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022. The Company filed its statement of defense on October 25, 2021. The first preliminary court hearing of the case is scheduled for January 23, 2022.        
Fidelity Venture Capital Ltd [Member] | Mr.Dror Atzmon [Member]            
Loss Contingency, Damages Sought, Value $ 450,000 ₪ 1,436,679        
Gain (Loss) on Contract Termination 256,000 ₪ 819,000        
Investment Owned, Balance, Principal Amount $ 415,000         ₪ 1,329,650
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Events During the Reporting Period (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 2 Months Ended 9 Months Ended
May 26, 2021
May 07, 2021
Mar. 25, 2021
Jan. 08, 2021
Jan. 31, 2021
Feb. 28, 2021
Sep. 30, 2021
Sep. 30, 2020
Subsidiary, Sale of Stock [Line Items]                
Proceeds from common stock             $ 5,035 $ 6,094
Exercise of warrants         725,000 725,000    
Exchange of ordinary shares         $ 797 $ 797    
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Stock issued during period, shares issue     2,618,532 1,569,179        
Proceeds from common stock     $ 3,300 $ 2,008        
Net proceeds from from offering     $ 2,872 $ 1,700        
Price per share   $ 1.26            
Underwriting discount   $ 463            
Over-Allotment Option [Member]                
Subsidiary, Sale of Stock [Line Items]                
Stock issued during period, shares issue   392,780            
Private Placement [Member] | ShoshanaZigdon [Member]                
Subsidiary, Sale of Stock [Line Items]                
Stock issued during period, shares issue 2,500,000              
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Events Subsequent to the balance sheet date (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Nov. 04, 2021
Oct. 26, 2021
Mar. 25, 2021
Jan. 08, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Oct. 28, 2021
May 07, 2021
Feb. 28, 2021
Jan. 31, 2021
Subsequent Event [Line Items]                        
Exercise of warrants         $ 25 $ 83 $ 822          
Warrants to purchase shares                     725,000 725,000
Common Stock [Member]                        
Subsequent Event [Line Items]                        
Exercise of warrants, shares         26,802 75,000 751,802          
Exercise of warrants         [1] [2] $ 1          
Stock Issued During Period, Shares, New Issues             4,580,491 2,439,802        
IPO [Member]                        
Subsequent Event [Line Items]                        
Stock Issued During Period, Shares, New Issues     2,618,532 1,569,179                
Shares Issued, Price Per Share                   $ 1.26    
Proceeds from Issuance Initial Public Offering     $ 2,872 $ 1,700                
Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Warrant expiration term                 5 years      
Warrant exercise price per share                 $ 1.26      
Proceeds from Issuance Initial Public Offering   $ 8,500                    
[custom:NetProceedsFromIssuancePublicOffering]   $ 7,560                    
Subsequent Event [Member] | Settlement Agreement [Member]                        
Subsequent Event [Line Items]                        
Claim amount paid $ 275                      
Subsequent Event [Member] | Warrant [Member]                        
Subsequent Event [Line Items]                        
Shares Issued, Price Per Share   $ 1.352                    
Subsequent Event [Member] | IPO [Member]                        
Subsequent Event [Line Items]                        
Stock Issued During Period, Shares, New Issues   2,514,800                    
Subsequent Event [Member] | Private Placement [Member]                        
Subsequent Event [Line Items]                        
Stock Issued During Period, Shares, New Issues   3,772,208                    
Warrants to purchase shares                 440,091      
Warrant exercise price per share                 $ 1.69      
Warrant expiring date                 Oct. 26, 2026      
Subsequent Event [Member] | Private Placement [Member] | Warrant One [Member]                        
Subsequent Event [Line Items]                        
Warrants to purchase shares   2,829,156                    
Subsequent Event [Member] | Private Placement [Member] | Common Stock [Member]                        
Subsequent Event [Line Items]                        
Warrants to purchase shares   1,886,100                    
Subsequent Event [Member] | Holders [Member]                        
Subsequent Event [Line Items]                        
Exercise of warrants, shares   2,625,908                    
Exercise of warrants   $ 2,889                    
[1] Represents an amount less than $1
[2] Represents an amount less than $1
EXCEL 36 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

B#R?GZ8C0=-3U\>2(0S#$X*BJ.XW=0'QCAD?@3_7#K6EHEQ %T9Y%NU? M*DG^:VM41ET@=724 34=1?%MN7=RR"(G0Z0YO(UU?8%0: &GS]2<&"L6]8P8 M!"6,H(S$Q/)WW/OAET6W4%.(]X"6HN8U^69H(*-L5G.GO<_$V[*SR>NLH?O. M+9DT1(MJ)8NZ@:9 2VLH)5O3B"(I&7V=98K8,6/4W"*/7S*C4YG2Q(LF=E_< MUTUIB,PUPMB0H$^W.O?N>=>VXVR*%>"!#4T!-)8-M0SE!AFR;'8Q_W4TA9()!2+2];])K12=M9=KHM&MNZGBBF7RF'%ZW?C$%7:F":@B!N:*= M*D]?BURR&HK;]8/^!MQ>&^"A/_9TUHLE>0M,0,3% MZ(EX?:Y]53N/=CZ0GQZ:D$_&X]:JGY11#H&<6E=9Q]5'W,BG-XPF?HY1J-GY M%/+8TO<1P6-5U^P=[6H.%#461#8&4B1*7 B%VB9&]E?2^.MAL^#EQ,CDN7$0 MMT -E\LY2$US!L2V+>([YHDB@LA0/12_4T M76 <.EX$3>QA=J4<5^(TV^_WU0)U=(=3WD#F;T83+7%(?')%C8\&_\604T9P MP&R-?\Z([GE_1F]G@,Y1*>NYPEJ@CDH)V0'@IN)6%P%G3\'%Z!7$]?5U&G]= M%M52BIO[>)G$RY_NXRY>T71NZ,[:E.P]_%Z6U?O.7$J*5%Q)C"#B0XC/7R-GD,WT M>'Q^"&#VH>)0DJCHV+(N%K(I D[%[J"?NP]7=W^\R%NJHYO.-N9H2A69")($ MT9!@%J"&?OM(YVOS9VT8@$TW2?_B^3;6WASF=N5?S1'NX+?('@E4-+FZ8? M MH@>=$U$:]34\3U8NX;U!M'FYT/4R&Q7B-,;HA%=B.<5EXY:%LW75.(0AB4A5 M6."I4+7LLPD4,[WVF"'IU1C/6%3-@JM5NY/ 7\771P3-V[7HL6D/D^93&73CJ9)^)_-5&8A%TQ.T51D-5HS!!45">!N6[/8?\'5M'"E M;=$](7E;@*/V:QT1ENR>W]"W]B++<=L9UF<=?U>87Y;P+<*9C+8)![21>+TP M,9JQD/"HR]36=F[4\C&AHDW1%6.RF;7C7-7OT%H8VTC ZFNE?Z_*1$)X648X!(R.+<87;S%] M.VRWKZ_:-Z@;9N!=NXI"2\,@.*R)U- 5BJ0M%)U=9WV[G*+O-]S,;M"ZX^SV M55O>?]?6G^9[;XIDT[SV7A%UG6^?:[LZ,D7)* 1_%O+<+K2Y?3IZ)YL7H(_& M/L%4W^WJ<$I8>O=P5&H.;:.AJ?' ^'B5Z!X$6S%7UYF-@1;\D\ #RE!"_!\ M;A&:YH(.Z#[%7?P74$L#!!0 ( /*#;U.=&PO M=V]R:W-H965TQT28 F M:;$,Z!HT7?M,B]<6$8I422JN]^MW+B5_-&@#=,!>8E'BO??<A:QKIM]=DW.9R-!WM7GS0ZSKRB\G512O7]$#Q[_;> MXS39:U&Z(1NTL\+3ZG+T>OKJ^H3OIPN?-&W"T;-@3Y;./?+A3EV."@9$AJK( M&B1^GNB&C&%%@/%ET#G:FV3!X^>=]K?)=_BRE(%NG/FL5:PO1XN14+22G8D? MW.8/&OPY97V5,R']%9O^[LE\)*HN1-<,PD#0:-O_RJ\##T<"B^(' N4@4";< MO:&$\E9&>77AW49XO@UM_)!<3=( IRT'Y2%Z?-60BUFWU2E?21O'FB6P, MXK;SVJY%K$E\H-;YR*=[\MJIBTF$39:<5(/^ZUY_^0/]Y^*=L[$.XHU5]$Q^ M JQ[P.4.\'7YHL(':L=B5N2B+,KI"_IF>P)F2=_LIPEXV?EOC)WLC9TD8R?_ M&]LOZN<*?A5:6='E""4:R#_1Z.HO%RD[$[^)G[.>R;%X;[,_I>U0K6+1,YZG MNS>N::7=BLI9U561E)"B[99&5\*M5I1TNI70L!"H@HVH*>"&#QT;CTYL:EW5 MN"!T"!WDI_GIV7D^G9^+,B^*!<[SHLB68W%W@""M$F]IZ=.A!R-%[8PBS]8V MTGO)3M%7\I4.T+I_!8NP7M6H7S$O3V&B$//S>58E']])?!)X_1]=K"7(YE/E MF@:M!E5;/;[H;IF?31?YZ:P4LWP&+&6^F)>9&M!LQ?Q[4 99B5ZFE.:F)HV8 MG9?Y?%&(Z;@\$R=GLXSV2LJS%[24^6E1, _9*I%L9"3774 %AT"X&@AF"0R"=IU&%E+*"A#!L9"#;PW L7U(9RTYH,G3-X>/'H,A M(C,!V^A&1WE0 LDAD8_-CL7'&EWBX&1B!P\8:3WY/%(YG5N>T.'(DM+!=VTR M,,X^'J472NR8)6AKT'^2(J:!-22EK4&;$JUWJ!7,,('](A43:#)N2S"F>68C MPY1$0F LQOHH--#[I=,^60&"NT--Y%QL2+7X#%0@LEP[" D"Q=U!8;\!'+;\ M;ON@_Z&[VZ%4AG07$,8EE#PKJ&7J 1)-LNJ0KDYTRRVDK;\/*9 M +5(%BN8%*+&IHCDZ>S.$?8+Z*R+ TW2.DT<1(GS)Q6S-PW[02 5-?; M[Y."VP<3.C2@76_-=ZTCDT-32=%M,!^6M*LB)89FQFCV1("S"!4QQ:LG8BR^ MMP5-CO9/Q&R=MNS0-^=^%=V_W2_RK_O]]7"]_R\ HWB-N I#*X@6X_GI2/A^ ML^X/Z$5IFUVZB 1)CS7Z+GF^@.\KAQP:#FQ@_^_-U;]02P,$% @ \H-O M4U #[NF'! H0H !D !X;"]W;W)K&ULM59+ M;^,V$+[K5PSRS:HA>N:$@LZ61FK MA:>E7?=<:5'D04FK7IHDXYX6LN@LYF'OP2[FIO)*%OA@P55:"[N[166VUYU^ M9[_Q1:XWGC=ZBWDIUOB(_K?RP=*JUZ+D4F/AI"G XNJZ<]-_=SMD^2#PN\2M M._H&]F1IS!,O/N;7G80)H<+,,X*@OV>\0Z48B&A\;3 [K4E6//[>H_\4?"=? MEL+AG5%_R-QOKCO3#N2X$I7R7\SV9VS\&3%>9I0+O["M98?##F25\T8WRL1 MRZ+^%R]-'(X4ILD%A;112 /OVE!@^5YXL9A;LP7+TH3&'\'5H$WD9,%)>?26 M3B7I^<6'9RR\@\=JZ?!K1=_@#?@-DJM*%!E"71JY\#CO>3+(:KVL ;^MP=,+ MX#/X9 J_\1T99MNF=[F[X)^(AE%P9)#&F2]M_ &[3>#P+>X!+> MP>TF$'_=+)VW5"M_OP$_;.&' 7[X_P3W;?![XS&:P _P'ZQ$H@N?"_B<>;-$ M"^FXCF0,&Z-RM [,"K;"6L& ^((VDPYS$-0]Z[7%-4.02!J/TU$\2Z;T-9W. MHB6C1BWJ=(_*).Z,+D6Q T<60!(0M?):.H^6@'-IJ3O)Z@JM+-8$-^H/XVF2 M1&XC+ 8^DJAD1FMJ8>J&["D211[72)DILLI:=KFT\IG80:E$AG1I^/B$-0/U MB>LX[A-X51QQ:/WU)BHKFVVHQ^%@_M@T87J&;?F2U2Q@7T&_.QBE44G^!UT2 MH[@Y9S))YO.HL=*%C\0JSR5?23$0,,?("8V4G]VEB'WC' SBR22-TV1ZZLMK MVE&@';A<\AE:GZN2EZ^C1AE.9W%_-([.QX1"$K4^M%AU8(1C_GQZ.>==^)7. M6T(<.JDUYAPVM=L7H5BJ.J1;J11ME@0"*[K/88>"ZK;?3<&$=9:.1[\XR: M]X?G&IF@0QYET=BEA]NKVO -%4[]Q=3#Z2_B'V'A05@OT77AH;*N$H<[ZIQR M'!W;XX!^ T0NDG!PG8J1TJ;IH@JB+@ &C?>HQ)8+ZJ:9 .CX\?W]G\WZ52^6 MI\RBL\Q.(G'@8%'J)>G3&3_95+P%T, $- 5QOY34)U2/;?:9B R9=I*N71'8 ML3RCY]*1,TXHON@(62'GC;M.":G9(-K==OZZJ<>.@W@]O'T2=DVL0.&*5)/N9-0!6P]$ M]<*;,@PA2^-II F?&YHAT;( G:\,/6?-@@VT4^GB7U!+ P04 " #R@V]3 MH;3_RGL$ ;"P &0 'AL+W=O2-4ML T[:;7TH%M3+]C#L@99.%AN)5$DJCO_[W1UE MQ6ML!]B+38F\N^^^N_O$Z<:Z!U\B!GBJ*^-G21E"W7KH&X]+@._&,ZGC5KC$L-]<^?H:=A[R76-QFMKP&$Q2Q;CJYL+/B\'_M2X M\7MKX$Q6UC[PPZ=\EHP8$%:8!?:@Z.\1;[&JV!'!^-;Y3/J0;+B_WGG_17*G M7%;*XZVM_M)Y*&?)90(Y%JJMPA>[^0V[? 1@9BLOO[")9R_.$\A:'VS=&1." M6IOXKYXZ'O8,+D='#":=P41PQT""\H,*:CYU=@..3Y,W7DBJ8DW@M.&B+(.C M74UV8;[4:Z,+G2D38)%EMC5!FS73H>!XK'5,.M\WT3?DR.^ M?X;/UH32PT>38_Y?^R'A[,%.=F!O)B<=+K%)X6ST#B:CR?B$O[,^^3/Q=W;$ MWZ&$_UZL?'#4+/^<"'#>!SB7 .=' MP;U>8Z8 Z9)0Z,CRM/P7+%KPMME,FT MJL '>D'='OPAHD^&X<&]\HW*<);09'ITCYC,0:7PO^+#'R4.%%%3-\ILF9SV M-3?:!'2Z/NQ.FZQJJ0&@1(?:0*D>$5:(!@ALHQSMK+802H3;&)(L@..[G)SA M8*-#*=NNK:A RN2D!NNV4CS6'FPAF_=& "XYKH3T?7RXZVLQM=O4T[]U6P'![.D/( IMY$34T2P8K[+(]7/IL-*D1DQ'.KA%%TC^ MR4G\2$2]_M;JKK3WZ3*%-1ITA$[<8\.@U?/X$6V45\/UW=7EU\7B;E<8"NQC MW.>24#JVUB%F_Z)?3O8*E3R%WQO"(\&)#=)P+PSQMJ'Q@CI*%[)T43L1X'J% MKEQH2=85]RW.2DI?V8&7:2=ZU"J0%7>4A* 3PU]DGCXN"+$=]&&EKP1 M'FTEKQV0+2K'"!CD!XH3$8PC FE6?[!=!Z_/N"]M6^4,AS_ES"#9?&U-_%;V M(]Z%>"4#4#X1,R_,8>/:#?9$967^?V"B%$\I[T2OOQ6GE)6:H!NB# MKED1#HGJ20]'1'5%HOJ=:Q&-*&6Q]VGS=;V(C// Z+"-A'/'[P;'0TNL6>J9 M!]P+Q0VM/-V@FMC0TE>J**BAA%=5Q\DE--;)C)%!KGU66>X+"GI4EF38V<6^ M\DOU2"*RT-+I73=GTCNYIK@.&)C3,MF%LS7[\'N0TT/%'.Y=6&IT:[F6B5\3 MXMVE?]O?_!;QPO-\/%X;/RNWUL1$A069CM+W5%47KV+Q(=A&KC\K&^@R)&PO=V]R:W-H965TH@$T:1)L6;=$#+8TM(A2I)2D[Z:_OD)(5%XT#%"AZL,6/F3=O M'H>%=0O1?%JQ M+:9HGZH'3;.H0\EYB=)P)4'C9A8NAE?+L;/W!C]SW)NC,;A,UDH]NTF2S\*! M(X0",^L0&'UV>(U".""B\:W%#+N0SO%X?$"_];E3+FMF\%J)7WANBUEX$4*. M&U8+^ZCV/V*;S\3A94H8_P_[QG9R&4)6&ZO*UID8E%PV7_;2ZG#D<#$XX1"W M#K'GW03R+%?,LOE4JSUH9TUH;N!3]=Y$CDMW**G5M,O)S\YON60RXTQ (HW5 M->EM#9Q]96N!IC>-+,5PEE'6XBT;O/@$WB7<*6D+ SPT((^,D6J.%H&7Y?K$D* MJI<_/H@W[N*-?;SQ*?YTC?):(*@-W#*N8<=$W4_\#V.Y"WQE*I;A+*0;:E#O,)S#@4'PKQD$)+[%S['GR"X6!"_W>_ M!FGRV\TY)/?7?5C6F%H%UXI*3AK,W<@HP7-F M:9)(BYJ71\FFEC;:0G^2K,XYV?7@J9_V@UP)P;1Q[&RA:D.*D!6^9*0$F()I M!()E7JF*='E;ZGDFP8A8G[A41,OV>\$*LU;3H==T\+]I.KF$3X$;TH,64-F# MI +RJ=A"(T+IKJY+BRO*&MT-AG^6@'=PO,_!86C,U%;R/\EV2TT SH0RI@=G M[JW,@1[>;[5RY] 0@TKSC CMN2T"!CDWF:J)>4ZYTQFVE%\)E83C_N4V#H3? M.:I>;0*GVG6AW\]USPQ\!^//$(]A>$&*_6>"BZ.KL2*5=LRU%..JE7[O/1;1 MTMZ;F%)+M=4YHH'GLA!ZZN7&5&/?UTF.)=,7LD)!;S92E;.+NEFHVD3M3<(%+!7I7EDR]++"0]=0+OTVM#6F#7/K!_<;53+6NF\5H6OWEJ\JDW M\B#%#=L5YE[6WW!?S\#R);+0[A?JQKY#LM)'E'DP9E%PT3_:\UZ$#& 5' M -$>$+F\FT NRQMFV&RB9 W*>A.;-5RI#DW)<6'_E)51])83SLQ61B9;6%!= M*5S+DOYKS9Q>(;"F.=_61/N6@HHR.45W GAH,,@#0XAK%V04PI&PCU%9BK)@8D4;O")QKNRZ+/>BE'? MN.L[IK9HN,CIE;E>U0'K(EE :=RUJTZK;);*<%T%J]54?9I#LE!YG/ MW^J1ONH!81!#&%U"',-P\!&F5_W*5K_PL@^C(0Q#Z(AJS=YJ/:)TA@,( M^Y3952\>!!"/1A"&(XBB ;S7\7YGO92H,K=$-87>"=-LFO:VW=/S9CV]NC=+ MGCHBXT)#@1N"!A?#@0>J69S-P&ULM59M3]LP$/XKIX@/(#'RGA345@(*#&F@BHY-&MH'-[DV M%DGW<\SQW/N?.W07CSR)!E/"2I;GH&8F4LS/3 M%%&"&1$G;(:Y>C-A/"-23?G4%#..)"Y!66HZEA68&:&YT>^6:T/>[[)"IC3' M(0=19!GAKQ>8LD7/L(WEP@.=)E(OF/WNC$QQA/)Q-N1J9C8L,(EIJIF4'[]J M4J/1U,#5\9+]N@Q>!3,F B]9^IW&,ND9'0-BG) BE0]L\1GK@'S-%[%4E/^P MJ&Q]UX"H$))E-5AYD-&\>I*7>B-6 /8N@%,#G'6 MP/@U@"W+<"K 5Y;@%\# M_+: H 8$;0%A#0C+9%6[6Z9F0"3I=SE; -?6BDT/ROR6:)41FNNC.))@K[=]SO##HFO/5K+6RNMFT/V(32'B4@/H:5-V;JX(^ M4^59 KZH%B%P6U 5H[_J;N"\=7;@;3I[&JZ%OH-$*/O:4AHU0^-\S&6YLKK66HTT+)[ [V[>_ MTWC:V>OID-.Y^G)@F)((2Q>7^PV_890PD9"<_*#36/7W%IDX;61//S83MO6W M$UE[(ZQH;X4H='THN"H:,$1.6:RD$\)1',.]NMN4%MN;D+7Q<3B^I7]K>V^N M-$Q]X[HC?$IS 2E.%-(Z"14%KRXQU42R6=E#QTRJCEP.$W7Q0ZX-U/L)8W(Y MT6VYN4KV_P!02P,$% @ \H-O4P<'S95&! .1$ !D !X;"]W;W)K M&ULO5A+;]LX$+[W5PR$'E(@&SW]2& ;2.+$#9 M0;/M'H(>:&EL$9%$E:3L=G_]#F5%MA-9=9-L+C8?\\T,AQ^'' V60CZH&%'# MSS3)U-"*MX:T$5:0ID[_.,!'+H>5:CP-?^#S69L >#7(VQSO47_-;23V[ MUA+Q%#/%10829T/KU#V9N'T#*"6^<5RJC3:8I4R%>#"=JVAH.<8C3##41@6C MOP6>8Y(83>3'CTJI5=LTP,WVH_;+"Z2?WBDXZ'5MR#"&2L2_44L M/V.UH([1%XI$E;^PK&0="\)":9%68/(@Y=GJG_VL K$/P*L WA, &6X&^!7 M?PH(=@"""A#L:Z%3 3K[6NA6@.Z^@%X%Z)6;M8INN35CIMEH(,42I)$F;:91 M[F^)IAWAF:'BG98TRPFG1W?$[:A($,0,+AF7L&!)L>KQC&4A9PF<*H5: C>&@X^?X"/P#/Z.1:%(6@UL32X:0W98N7.^ M8'X'O'(+G>&Z# M/^/]X4[3;X%NQ]&NN^:4^?Z>^&8U$<(89M33<)BR# M,5=A(E0A$>ZO:1JN-*;J>XNYH#87E.:"'>8FE(CA@'030RGI4:9](,).B>L* MPT*6)&YBZ$IKM]1J,OEBY 4#>[&YZ<]%_&V)B^<207=;Y/*YB-NO1;96W*E7 MW&E=<7F OYD#? A765YH=0C7N, $7+B_P72*LBVPW=I,]SWVL5>;Z[6NZBI; MH-)T_6F37/;=QK-VI??N]Z:];P699\&)REF(0XON?85R@=8(FH[U&^F9O%[/ M5LC[=KK.^$YWW(+B[<0F[ M_P?%?Z-U!\AMQS;87)]+[G^ M"XGE[T6L]8WD!N]"K/6%X+;?""\E5KO67<1J1?U!]GPK19,W4+0=^/45Z79? MQ>)6] L<,Y?I]L@ZU[OMR;YY-\]^@Z)"\(..$3+#6%,:Z%@B0FJ>WY#3ZD6D M ,TK'.@9JLM#5#]E2X!Y51Z"T2$Q%/.,_TNR\XU'VX&I,2/S=OM1"$VM%7\A MESRD^F/)=?R!043'1Q1$\(CJ%BT>F?V+M"I-DJ;B548)OS&NJIC1Q"=3X1C3 MC4<"EDQ1*1-TP0O [8/?%'E[H^A*4<[+>EI!Z&ULS5=; M;]HP%/XK5K2'5FJ;*[<*D("PK=(JH;)N#]4>##D0BR3.; /M?OUL)P0((6JW M/O2%V,YWOG/YC'W2W5*VXB& 0,]QE/">$0J1WIHFGX<08WY#4TCDFP5E,19R MRI8F3QG@0!O%D>E85M.,,4F,?E>O35B_2]^F> E3$(_IA,F96; $)(:$$YH@!HN>,;!OQ[:K##3B!X$M/Q@C ME1>*#;KY GU%!\:@,G-W#*!MX9 SJCBT^7Z!,B"?H>TC7'2<"[II"!*#ISGCL=9DZ=,TY= M=$\3$7(T3@((*NS]>OM.C;TI"U!4P=E58>C4$DXAO4&N=8441U+:);4K,%X)XU=@[*97TKL"U&Y5ZVT?W+IV;=9?( && M(UWF02#O=<(%PZIG>HOLMK/WYWP0X?>WC.V^O_#NZ;'NE86OP%B=LO*GH';Y MCUY%='!B9&F;!ZU7#&RI>UXN$Y(URZ[<8K7HJP>ZFRRM#^W;D5VQ[JL^7+=Z M>_JLB93[!:5B M-U$.BJ^3_E]02P,$% @ \H-O4_^"/K]#!P 7"H !D !X;"]W;W)K M&ULS5I+;]LX$#[O_@K"Z*$%4EM\2+*+)$#BO-RM MVZ!NMX=B#[3-V$+U\$ITG #[XY>49%&6*%I&4L"71)+G(VF'G_#1]=A^?GT9K[GLANX]!L@X"&C]?,C_:G'5@9_O@J[=83.:GW4LJ1'SV8S+(:CX]\B&S/?E2$*/?_-!.\6<$EB^WHY^DQHOC)G2A TC M_X\W0C9NANV]C?<.ARF'N]EL9@&\A7E]/PT MCC8@EO)B/'F19D.*%_'KA3)Q)SP6OWH"Q\\G/)K] I?)]<@;=OWH$WH >2)8U9 KP0? \]GIR(A^+ZVS): M)S2<)Z<]+O23L_1FN2Z7F2ZH09KE/^YF6SW[YL]CLS_.,Z-,X^VN\W#!O1'\WH&S;M M1OA/^U M1W_9,9?K%>= %L7KEQ"[@UT,%[(A.+=$1%.J)T/-SD2)E3[Z?U=+P0 M21@NF*!,#J;/H"QW3Y_3QQ<;&L_!ST]B2##B+$C^,2B$"X5PJA!I4&CHTR0! MT0/X(.XBV[+$6CZ68V"OV(YQI#".&(V;9!4L6\99:;EUY2,;RBFI &%_ M5\WKN@Q"]J[,35T&VQ5S;S4R_;[>5KNPU3;:6KB#1\+4,!$;&WFK*U5V;;&A M7.N&Q78*!1RC BIF G8<5Z^ 6RC@FKV=4ETV^5YO MNS4/.*CB;+>F([(&%6?7AT&85)Q='P=#I#>U7YC:-YKZ;1,51"RR\U&4!\9" M M%R.6ZS;$)2SMP>"!NBYDKNI3(Q^KK,3 M9NR$RKF@:BE$OG&CCZ*_1^=^@R( M_A!X2;*FX8QI*1;5EX_LEHR<3.N"R&HN+5"Q%#33U(L#\ 1\R9;^!%P_L7CF M)=G6]I[%7J3W0YV3"+$;JC14E 3-G'10ZH+_I+6!L#,K;BU2&BK"@/:1)+6B M$'@HAS0GRB6LDP@D%L*5K!YJY(Q!J?@&[B&L M"%EP'WO:%+W,5>V7%Z-KD083%<] ,]&,PEF>D?U/=U%:+/178RON@30%!BM80/(X"@DKME9GDCBDE0>B<\5;R$S;[U@LYN/O+-=@(Y3;1;&&CGB.(U=+%)L MA\QL-V&^>+0 TI=C&O]B7-[E)-?&J_D5ME= M(T,J,C<:&>A4^WB-4+_!V5@1%MY#6(<<6N!Z>U4]H=*(X*JQFFX..E5CZT*V MTV!LZ:S1S%RW+!2%TD\C^V(>B#U)PK-W#P>%MR(C?"1DA!49X19DU#J\-2=U MI.IPC4SMF$HCU,=5CVL&#.=O*8GVQB%D673O[L(*-2T^WY^Y?PG;!KR@0]X\D^!6S83.S M_>:7#7>XWH)I3JE&>\5V7S8H-B7F9NV "A[^_ @((I-R9&T:$0Q'C$SGB$( M=O?/)9D]?B>:3JM;J0JC/4*[UBA*(V9**Q24G)9I"+ZL>2*\/!>!<")V<%R& M\S.XHERWWQSMF>"*S=+WGW_^\0>R$#*YH/1:[#7?BY'Z?KCVSJLN@QO.GHBB M2F*FRI>GDVR+VJ238C/B'$DZ*=8A>UCG]];4$:F_OC(52T5/Q-RAO7X9&)'Z MV6/#>S:B*(N8*>O%^7VW9P)C?N=VO6"$W7?)BLKLWTUE+?+.5C1F'PF-V8K& M[!8GC6UK:#Z68ZJA&AFG>G+>*WT()K^['--XX84)\-F# %E=5Z1IG'W*F-WP M:)5^&S:-.(^"]'+)Z)S%4D#\_A!%?'LC/S&UL[5=M M;^)&$/[>7S&BIRJ1$'X!&[@"$H$DS2FYH".7?JCZ86,/>'6VU]U=ATO5']]9 MV_$YQ\N1MO>M00I>>YYGGIF='0^CC9"?5(2HX7,2IVK-J:C(I["SD9B5S'/,6%!)4G"9-/ M9QB+S;CEM)YO?.#K2)L;UF24L34N47_,%I)65LT2\@13Q44*$E?CUM1Y>^D4 M@,+BGN-&-:[!A/(@Q">SN K'+=LHPA@#;2@8?3WB#./8,)&./RK25NW3 )O7 MS^P71? 4S -3.!/QKSS4T;@U:$&(*Y;'^H/8_()50)[A"T2LBO^P*6W]80N" M7&F15&!2D/"T_&:?JT0T -[#\"M .ZQ@&X%Z'X%<)T]@%X%Z!T+\"J =RS MKP#^L8!^!>@7FU5FM]B:.=-L,I)B ])8$YNY*/:W0-..\-24XE)+>LH)IRKC$-."I@:0@SD21<4[5I!2=SU(S'"MXS*9DIFE-X SR%NTCDBJS5R-*D MPG!90>7QK/3H[O'X+H\[8'MM<&W7^;BP7%TOX>2G'P==W_UY M%]?\,-<2LPZX?/6)>,6 MY+T]Y.^%U!&<)QF7"-?TF<%O-Y@\H/S] 'NW9N\>9+\62L&7JGQJPYPEU!05 M+$5.;:4-]RS.<=P!L,1]9C:[B_ '>,4?>OW>!EI0T.!6 M![1#[10))Y4&FB=B3GV>Q@((1"XU1,@D[>6KM) _R@8$ILHX":$!)LR-+)I= MX!U+D+/LYL]H2R7TFS8[*B]KN_WA[M[AV-_&4_L@](O:9J&$Q/ MJ2D/$X2D\17N4)I*V'>T*U:O(%OZ+RN[%XGOND/?^SH MJS$BFM\8-TRN>:H@QA4A[4Z?4B7+L;U<:)$54^.#T#2#%I=TVD*4QH">KX30 MSPLSB-8_GB9_ U!+ P04 " #R@V]3A;R.@Q($ W#P &0 'AL+W=O M4A.=YR\2@S M (6>BIS)BT&F5/G)<62204'D.2^!Z3]++@JB=%>L'%D*(*D%%;GCN6[H%(2R MP61LO\W$9,S7*J<,9@+)=5$0\?,2!,QB59P1S40SD3 MNN3'XC#_=XM@ K,7O%+9RKXW,4!:H!Q08?PG/I7VB;6WK#E"REHH7-5@S*"BKWN2I3L0> /L= *\&>*<" M_!K@OP0,.P##&C \%1#4@.!40%@#PE,!40V(3@7$-2 ^%3"J 2-;#M7\V2BZ4ZTD-O MH]VH$SU]#2W.D1=TPJ_[X;\0=H[40_?M6F MZ%9!(?_J">0W@7P;:-@1:"9X I!*M!2\0 DO"JW)TD1JRV'E*[2^S,:RF02N M'XR=S7ZFCHU"=S1LC YH#AN:PUZ:UT\@$BIM'K9F,>JEVU9BE9=@+W;D!:[K M'E+\\JK9 ^_[*"KX^-]($O;J>) MW=WVZ/82_:[/F^4!6?O@RR68?+=N*>XQDSAZF=@6*QQUK3>\MYWC5Q)+$S!5 M4%5 ZX99>8CW(Y][84?DG3YCKS?R TM!; 6UQX64RH2OF6J-[QV-?!CZ'>%W MJHW[9?MN ^+CYSSG2A_%%;HK[5GZA&6-=XJ+AV^[L/%.-W&_<4V,D3_I*CTQ\3M!Q6^L MJ'@GJ?C--/42MXBJV4./5K6S=UXW5TI]S%Q1)E$.2XUTSR/M0E2WM*JC>&F/ M\ NN](7 -C-]LP5A#/3_)>?JN6-N!?(O4$L#!!0 ( /*#;U.V6WOI MKP8 -LA 9 >&PO=V]R:W-H965TB"WK6ZU6N]^N9!\_9NP'7U JP%,2I_RDLQ!B>=3M\NF")H0?9DN:RB?S MC"5$R%MVW^5+1LDL!R5Q%SF.WTU(E';ZQWG;F/6/LY6(HY2.&>"K)"'LURF- ML\>3#NRL&[Y$]PNA&KK]XR6YIQ,JOB['3-YU*RFS**$IC[(4,#H_Z7R 1R,W M5("\Q[\1?>0;UT!-Y2[+?JB;X>RDXRB-:$RG0HD@\N>!#F@<*TE2CY^ET$XU MI@)N7J^EG^>3EY.Y(YP.LOA;-!.+DT[8 3,Z)ZM8?,D>+V@Y(4_)FV8QS_^# MQ[*OTP'3%1=94H*E!DF4%K_DJ33$!@"'!@ J >@9 +H& "X!N"W +0%N6X!7 M KRV +\$^,\!V (2D#0=H2P!(1M1^B5@%[;$:"S7CFG-:1:[.>K#7T39+W< M<&N]33.!ZP6'K5<!DE4:KH82*8?!I)G.A_?*"IX&"RNN/TYTI> Y$!L: RYF*23BDH2&I&! 7O MSZ@@4P"0@V #?&"'CZ;B$"#?"#^SPZ\) MDW#/"/]HAU^25"H?&N'G=OB$+@\!=HSPB_9PIP%^^7NC?_Z]T:_:+)S9=->[ M%NX7< (C^L:./J=WUL%'+98=PR9X5T9G%:*H"E&4R\,F4^K8S*,5W%[)'F H M:,*_6^3C2C[.Y;LF"GBB;!IQ"K(Y>%21+0FAR5L+*7XN154=#WWD'78[C MU!4=[>Q6T]6K=/6LN@ZR))%5T41DTQ_@]IHF=Y39%M&OY/I[<9*@DA^\V$D. MS$8^#[:LA_S00<_\9;M7L+T2ETV]X*:PVHS":D;A'W%[JQ15O1_Q)9G2DXXL MSSEE#[33!PUR/MFUN87?FRC^#PT^W#$X:AK\,MP*5=AL\EYE\IYUG,+KAYRO MZ R0]FA;CLK?E"JX7.FX/UEWF\W8_Y.*> MT6>@H\LEQSJ%X7C4)FSA1OT%]Q*X4*U$&@9;IMSN!0-3]H$Z M_4![_MEVMQ;.K),0W$\6@CH-07L>*G,]H$_+2.U!9"X5E"6-%:9=D@=^4<*X M32N=2J"=0+5694Y9YOZYE/[)#?YY58ILZ9^:8J&=8W_;/P?E +42S3-Y'M+, MB>S,>5OL9X]NU"%3H>.Y5'&M8:'86J^F?#0H!_!KA8!O4DPS,(*O"PGP'YA0 M(6*:J-8/]XP65RU"!FT4]_NI[I&F3F2GSD%,H@20)%M)Z4L2S9JVX:BAN@\\ M@VDU62([6=I,NXZ9-M;4](:\_5A34QSR_VPB&I0"@UJ@8\]0BB!-A$ ;Y=]. @0.)NS<];*M_54IK;8_P57JX#46JFSV<;Q[7+69Z-OW[Q!CJH[ MS*ZDR1'O(,=7Q >!OM;X+SV3K.]J>G3MQ=L+K5]*JVU0P]"'IA3A:A9U=["H MQ?H763RCC+>RK:9&%^_'MAO'JG;2>^&9W\#=/C)%/O)ZIC3@:LYS[5S5\JQN M4(JI;ZU# ^6ZBM;J+9I67'OMU7Q<=[H#]87FQW12^;= _I%T797'E$L/7LB& M=[8W!JXF)?P^?]_/P52!B[/QJK7XIN <'GW*7\8^ M:[^ 1\.F]@^N?S1R_88GTN;R2=#X)%Q_N-#52A6?/5P3=A^E7$YL+A5T#@/I M.*SXDJ"X$=DR?VEZEPFY:MO*V7.7@7N?O#VX&!P_>9LWW[8 &](Z"4]>03IT6" $P.( MD<>/(W^(&Z,^]5/_^O$32<<.Z24D;#,_G>1*[@H0$6>PD6G)@ALJ4C*C@L\U M!Z^DDNEF]@N@OL[;Y?O =L9 M".1"= )'Q!FFDXH:P[0\MY-F<6.\!P7M^&I3686%IIOAZ(3L')J;#3)7.F.Z M"S,D6]-T(E@.:^F ZBH[(964#MT-&X"_'TVQ]VG'3R)-ZCXC3(?5G8[LIE#I[ +S7*^;N;K MO!. L0]Q=EI58O->\$*6S&W^T0&G$[KU"Y9*\UL;#5IE80U,D^"&:<,7??2F_\J^X*]&MMC M\+F+/'D)(N.7(/)Y]F38'CN]L^W.R=99 WB#2,D7>%<1NZ#!?,6%X;*=+7F6 M,7GO@+/TAL[MB^8=?KL^8SE="7/5@2G9C3^SC*_*I%MU 8EH5^W&GV![P[A[ M?;&QN,S8FF6S=JJ+>3,,[,!&;2]PV$?.F\N/8#X.\R. 87$P!9B/\\+B_$_[ M&:/[<1BF;>Q%QJC/&/5Q7CYDUGRP.'Z?Q%[^G29)%,4QEM'9S*M@AN4MCN'K M9\.T@0<6!R+]6:[Q:N,=\G ?8#5]J$.PG>*=B.T4SS4@_KR!1Y+XJXW% 0^L M"ECO0'Q_'.@IOT\4054Q;=@3C"-)@B'0B_X>C6,D.S%\_/7!GI(H2A(_ IA? M011A"#R-.((I T8$D7-.;AW'H7;* MNQS $P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %( MMB6/:(7->=I3W;+T]! M;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B M':5_' MFC6 K46:#P;CM.8HDZO+0U\+G?H99:&PJ"05NH)'A)WY7>^R;(L&5RC0_IHF M;5I PFJ46.,KE--DD#"S5KLO2N.KDI:+9:&5$-,DZRH>05LLWA4O'>1WOC)M MB>6K!TX@TV0\H XKU,:V+=K^.3%N@1IWN<:J6Q06](Q;N-.JV:!\I"C .2H3\B1!SD.0([[A!Q[D&V6?>K;J:>C)M(Y\OZ)+X,G%3"M+-)^.RI:S1O@MB MR"599)GXR_!FZ\C8K-%N)=HUL W_"\Y!W\IZ\LU\!/F9(/WF?^F$G/F;P,M.G@(X^F7E(0'F? M CK&# DH;P64'B[5)50HH;RG5Q@JIPM^L=#,/;J#P7#D-F35"'%-9=_D5\7+ MPQW]\'_AZ@U02P,$% @ \H-O4Z_LDZ4X 0 'P\ !H !X;"]?N/B8UN WLCU1@%Z(]<;WZFW#X^6_-SS7//SWTEU&)^E M^?AI^=Q5DNY0*8&(W&K'0V@4W#U&KDL\D3U'*E4_:\P<=1 M.3O- ^B89X^[PM9KFDOOM2IEPGVVMM4WE^'>H<#.KB8VRLAB M)SKH=TYXPK"[\HO].YD^0ZR>+P?+BR[>436+9>?\=<9'_7/S"&(Y+@BDN.:2(X;(CG&1'+<$LEQ M1R3'/9$"54Z%JYP*6#D5L@HJ9!54R"JH MD%50(:OX3[*^.[?\ZR_5=BV,5/;@S[K? ;-/4$L! A0#% @ \H-O4P=! M36*! L0 ! ( ! &1O8U!R;W!S+V%P<"YX;6Q0 M2P$"% ,4 " #R@V]3U"^'ENX K @ $0 @ &O M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " #R@V]3F5R<(Q & "<)P M$P @ ', 0 >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 M ( /*#;U-M!IHL/04 .\5 8 " @0T( !X;"]W;W)K M&PO=V]R:W-H965T&UL4$L! M A0#% @ \H-O4UIOT#]Y @ HP8 !@ ("!V!, 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \H-O4U/P M3 =E @ 7P4 !@ ("!$B4 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ \H-O4] /.HA7! <@H !@ M ("!/S4 'AL+W=O&UL4$L! A0#% @ \H-O4_.+!U4T!P 2Q, M !D ("!9$( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \H-O4U #[NF'! H0H !D M ("!+EL 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ \H-O4SR'.-H& P R08 !D ("!66@ 'AL+W=O M"8# !6 M"@ &0 @(&6:P >&PO=V]R:W-H965T&UL4$L! A0#% @ \H-O4\M: M$2-B P J0P !D ("!<', 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ \H-O4X6\CH,2! -P\ !D M ("!I8( 'AL+W=O&PO M=V]R:W-H965TN4 !X;"]?7!E&UL4$L%!@ @ " EP@ /N7 $! end XML 37 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 122 213 1 true 32 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://mysizeid.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Interim Balance Sheets Sheet http://mysizeid.com/role/InterimBalanceSheets Condensed Consolidated Interim Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) Sheet http://mysizeid.com/role/InterimBalanceSheetsParenthetical Condensed Consolidated Interim Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) Sheet http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) Sheet http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquityParenthetical Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited) Sheet http://mysizeid.com/role/InterimStatementsOfCashFlows Condensed Consolidated Interim Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - General Sheet http://mysizeid.com/role/General General Notes 8 false false R9.htm 00000009 - Disclosure - Significant Accounting Policies Sheet http://mysizeid.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Financial Instruments Sheet http://mysizeid.com/role/FinancialInstruments Financial Instruments Notes 10 false false R11.htm 00000011 - Disclosure - Stock Based Compensation Sheet http://mysizeid.com/role/StockBasedCompensation Stock Based Compensation Notes 11 false false R12.htm 00000012 - Disclosure - Contingencies and Commitments Sheet http://mysizeid.com/role/ContingenciesAndCommitments Contingencies and Commitments Notes 12 false false R13.htm 00000013 - Disclosure - Significant Events During the Reporting Period Sheet http://mysizeid.com/role/SignificantEventsDuringReportingPeriod Significant Events During the Reporting Period Notes 13 false false R14.htm 00000014 - Disclosure - Events Subsequent to the balance sheet date Sheet http://mysizeid.com/role/EventsSubsequentToBalanceSheetDate Events Subsequent to the balance sheet date Notes 14 false false R15.htm 00000015 - Disclosure - Significant Accounting Policies (Policies) Sheet http://mysizeid.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://mysizeid.com/role/SignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Financial Instruments (Tables) Sheet http://mysizeid.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://mysizeid.com/role/FinancialInstruments 16 false false R17.htm 00000017 - Disclosure - Stock Based Compensation (Tables) Sheet http://mysizeid.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://mysizeid.com/role/StockBasedCompensation 17 false false R18.htm 00000018 - Disclosure - General (Details Narrative) Sheet http://mysizeid.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://mysizeid.com/role/General 18 false false R19.htm 00000019 - Disclosure - Schedule of Fair value of Financial Assets and Liabilities (Details) Sheet http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails Schedule of Fair value of Financial Assets and Liabilities (Details) Details 19 false false R20.htm 00000020 - Disclosure - Schedule of Stock Based Expenses (Details) Sheet http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails Schedule of Stock Based Expenses (Details) Details 20 false false R21.htm 00000021 - Disclosure - Stock Based Compensation (Details Narrative) Sheet http://mysizeid.com/role/StockBasedCompensationDetailsNarrative Stock Based Compensation (Details Narrative) Details http://mysizeid.com/role/StockBasedCompensationTables 21 false false R22.htm 00000022 - Disclosure - Contingencies and Commitments (Details Narrative) Sheet http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative Contingencies and Commitments (Details Narrative) Details http://mysizeid.com/role/ContingenciesAndCommitments 22 false false R23.htm 00000023 - Disclosure - Significant Events During the Reporting Period (Details Narrative) Sheet http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative Significant Events During the Reporting Period (Details Narrative) Details http://mysizeid.com/role/SignificantEventsDuringReportingPeriod 23 false false R24.htm 00000024 - Disclosure - Events Subsequent to the balance sheet date (Details Narrative) Sheet http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative Events Subsequent to the balance sheet date (Details Narrative) Details http://mysizeid.com/role/EventsSubsequentToBalanceSheetDate 24 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm mysz-20210930.xsd mysz-20210930_cal.xml mysz-20210930_def.xml mysz-20210930_lab.xml mysz-20210930_pre.xml http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 42 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 11, "contextCount": 122, "dts": { "calculationLink": { "local": [ "mysz-20210930_cal.xml" ] }, "definitionLink": { "local": [ "mysz-20210930_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "mysz-20210930_lab.xml" ] }, "presentationLink": { "local": [ "mysz-20210930_pre.xml" ] }, "schema": { "local": [ "mysz-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 265, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 52, "http://mysizeid.com/20210930": 8, "http://xbrl.sec.gov/dei/2021": 4, "total": 64 }, "keyCustom": 17, "keyStandard": 196, "memberCustom": 14, "memberStandard": 17, "nsprefix": "MYSZ", "nsuri": "http://mysizeid.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://mysizeid.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Financial Instruments", "role": "http://mysizeid.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Stock Based Compensation", "role": "http://mysizeid.com/role/StockBasedCompensation", "shortName": "Stock Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Contingencies and Commitments", "role": "http://mysizeid.com/role/ContingenciesAndCommitments", "shortName": "Contingencies and Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "MYSZ:SignificantEventsDuringReportingPeriodTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Significant Events During the Reporting Period", "role": "http://mysizeid.com/role/SignificantEventsDuringReportingPeriod", "shortName": "Significant Events During the Reporting Period", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "MYSZ:SignificantEventsDuringReportingPeriodTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Events Subsequent to the balance sheet date", "role": "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDate", "shortName": "Events Subsequent to the balance sheet date", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "MYSZ:UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://mysizeid.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "MYSZ:UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Financial Instruments (Tables)", "role": "http://mysizeid.com/role/FinancialInstrumentsTables", "shortName": "Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Stock Based Compensation (Tables)", "role": "http://mysizeid.com/role/StockBasedCompensationTables", "shortName": "Stock Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - General (Details Narrative)", "role": "http://mysizeid.com/role/GeneralDetailsNarrative", "shortName": "General (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_ResearchAndDevelopmentExpenseMember", "decimals": "-3", "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Schedule of Fair value of Financial Assets and Liabilities (Details)", "role": "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails", "shortName": "Schedule of Fair value of Financial Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Interim Balance Sheets", "role": "http://mysizeid.com/role/InterimBalanceSheets", "shortName": "Condensed Consolidated Interim Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Schedule of Stock Based Expenses (Details)", "role": "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "shortName": "Schedule of Stock Based Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_ResearchAndDevelopmentExpenseMember", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "span", "span", "span", "td", "tr", "table", "MYSZ:SignificantEventsDuringReportingPeriodTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-02-28", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Stock Based Compensation (Details Narrative)", "role": "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative", "shortName": "Stock Based Compensation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "INF", "lang": null, "name": "MYSZ:WarrantsToConsultants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2018-09-262018-09-27_custom_NorthEmpireLLCMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Contingencies and Commitments (Details Narrative)", "role": "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "shortName": "Contingencies and Commitments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2018-09-262018-09-27_custom_NorthEmpireLLCMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Significant Events During the Reporting Period (Details Narrative)", "role": "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative", "shortName": "Significant Events During the Reporting Period (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "MYSZ:SignificantEventsDuringReportingPeriodTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-01-31", "decimals": "-3", "lang": null, "name": "MYSZ:ExchangeOfOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "MYSZ:StockIssuedDuringPeriodValueExerciseOfWarrants", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Events Subsequent to the balance sheet date (Details Narrative)", "role": "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "shortName": "Events Subsequent to the balance sheet date (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-28_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical)", "role": "http://mysizeid.com/role/InterimBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Interim Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)", "role": "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss", "shortName": "Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-06-30", "decimals": "-3", "first": true, "lang": null, "name": "MYSZ:IssuanceCostNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical)", "role": "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquityParenthetical", "shortName": "Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-06-30", "decimals": "-3", "first": true, "lang": null, "name": "MYSZ:IssuanceCostNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)", "role": "http://mysizeid.com/role/InterimStatementsOfCashFlows", "shortName": "Condensed Consolidated Interim Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - General", "role": "http://mysizeid.com/role/General", "shortName": "General", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Significant Accounting Policies", "role": "http://mysizeid.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 32, "tag": { "MYSZ_ChangeInRestrictedDeposits": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in Restricted Deposits.", "label": "Change in restricted deposits" } } }, "localname": "ChangeInRestrictedDeposits", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "MYSZ_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant [Member]", "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_ConsultantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant One [Member]", "label": "Consultant One [Member]" } } }, "localname": "ConsultantOneMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_DisclosureSignificantEventsDuringReportingPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Events During Reporting Period" } } }, "localname": "DisclosureSignificantEventsDuringReportingPeriodAbstract", "nsuri": "http://mysizeid.com/20210930", "xbrltype": "stringItemType" }, "MYSZ_ExchangeOfOrdinaryShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Exchange of ordinary shares.", "label": "Exchange of ordinary shares" } } }, "localname": "ExchangeOfOrdinaryShares", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "MYSZ_FidelityVentureCapitalLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fidelity Venture Capital Ltd [Member]", "label": "Fidelity Venture Capital Ltd [Member]" } } }, "localname": "FidelityVentureCapitalLtdMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_HoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Holders [Member]" } } }, "localname": "HoldersMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_IncreaseDecreaseInTradePayable": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in trade payable.", "label": "Increase (decrease) in trade payable" } } }, "localname": "IncreaseDecreaseInTradePayable", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "MYSZ_IncrementalCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Incremental compensation cost.", "label": "Incremental compensation cost" } } }, "localname": "IncrementalCompensationCost", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "MYSZ_IncrementalCompensationExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Incremental compensation expenses.", "label": "[custom:IncrementalCompensationExpenses]" } } }, "localname": "IncrementalCompensationExpenses", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "MYSZ_IssuanceCostNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance cost, net.", "label": "Issuance cost, net" } } }, "localname": "IssuanceCostNet", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "MYSZ_MrDrorAtzmonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr.Dror Atzmon [Member]", "label": "Mr.Dror Atzmon [Member]" } } }, "localname": "MrDrorAtzmonMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_NetProceedsFromIssuancePublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net proceeds received from offering.", "label": "[custom:NetProceedsFromIssuancePublicOffering]" } } }, "localname": "NetProceedsFromIssuancePublicOffering", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "MYSZ_NorthEmpireLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North Empire LLC [Member]", "label": "North Empire L L C [Member]" } } }, "localname": "NorthEmpireLLCMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_RevaluationOfInvestmentInMarketableSecurities": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revaluation of investment in marketable securities.", "label": "RevaluationOfInvestmentInMarketableSecurities", "negatedLabel": "Revaluation of investment in marketable securities" } } }, "localname": "RevaluationOfInvestmentInMarketableSecurities", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "MYSZ_RevaluationOfWarrantsAndDerivatives": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Revaluation of warrants and derivatives.", "label": "Revaluation of warrants and derivatives" } } }, "localname": "RevaluationOfWarrantsAndDerivatives", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "MYSZ_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_SettlementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Agreement [Member]" } } }, "localname": "SettlementAgreementMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_ShoshanaZigdonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ShoshanaZigdon [Member]", "label": "ShoshanaZigdon [Member]" } } }, "localname": "ShoshanaZigdonMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_SignificantEventsDuringReportingPeriodTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Events During the Reporting Period.", "label": "Significant Events During the Reporting Period" } } }, "localname": "SignificantEventsDuringReportingPeriodTextBlock", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/SignificantEventsDuringReportingPeriod" ], "xbrltype": "textBlockItemType" }, "MYSZ_StockIssuedDuringPeriodSharesExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of warrants, shares.", "label": "Exercise of warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "MYSZ_StockIssuedDuringPeriodSharesExerciseOfWarrantsAndPreFundedWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of warrants and pre funded warrants, shares.", "label": "Exercise of warrants and pre funded warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrantsAndPreFundedWarrants", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "MYSZ_StockIssuedDuringPeriodValueExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of warrants.", "label": "Exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "MYSZ_StockIssuedDuringPeriodValueExerciseOfWarrantsAndPreFundedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of warrants and pre funded warrants.", "label": "Exercise of warrants and pre funded warrants" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrantsAndPreFundedWarrants", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "MYSZ_TwoThousandSeventeenConsultantIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Consultant Incentive Plan [Member]", "label": "Two Thousand Seventeen Consultant Incentive Plan [Member]" } } }, "localname": "TwoThousandSeventeenConsultantIncentivePlanMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_TwoThousandSeventeenEmployeePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Employee Plan [Member]", "label": "Two Thousand Seventeen Employee Plan [Member]" } } }, "localname": "TwoThousandSeventeenEmployeePlanMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unaudited Condensed Consolidated Financial Statements [Policy Text Block]", "label": "Unaudited condensed consolidated financial statements" } } }, "localname": "UnauditedCondensedConsolidatedFinancialStatementsPolicyTextBlock", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "MYSZ_UnderwritingDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriting Discount.", "label": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "MYSZ_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Two [Member]", "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "MYSZ_WarrantsToConsultants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants to Consultants.", "label": "Warrants to consultants" } } }, "localname": "WarrantsToConsultants", "nsuri": "http://mysizeid.com/20210930", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r271", "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Series [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://mysizeid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r144", "r148", "r167", "r168", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r248", "r249", "r259", "r260" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r144", "r148", "r167", "r168", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r248", "r249", "r259", "r260" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r144", "r148", "r154", "r167", "r168", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r248", "r249", "r259", "r260" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r144", "r148", "r154", "r167", "r168", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r248", "r249", "r259", "r260" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r116", "r213" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r35", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r7", "r35" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Trade payables" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r23", "r117", "r118" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r44", "r45", "r46", "r241", "r254", "r255" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r43", "r46", "r52", "r53", "r54", "r78", "r79", "r80", "r193", "r250", "r251", "r281" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r184", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r78", "r79", "r80", "r181", "r182", "r183", "r197" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Liability reclassified to equity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Stock-based compensation related to options granted to employees and consultants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r170", "r178", "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock option compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r76", "r102", "r105", "r111", "r120", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r191", "r194", "r202", "r214", "r216", "r233", "r239" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r40", "r76", "r120", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r191", "r194", "r202", "r214", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r11", "r12", "r13", "r14", "r15", "r16", "r17", "r18", "r76", "r120", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r191", "r194", "r202", "r214" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r171", "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r32", "r70" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r65", "r70", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period", "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r65", "r203" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Warrant exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrants to purchase shares", "verboseLabel": "Exercise of warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r38", "r129", "r235", "r245" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r126", "r127", "r128", "r132", "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Contingencies and Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r78", "r79", "r197" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r149" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock of $0.001 par value - Authorized: 100,000,000 shares; Issued and outstanding: 15,069,587 and 7,232,836 as of September 30, 2021 and December 31, 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r48", "r50", "r51", "r56", "r237", "r247" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Total comprehensive loss", "totalLabel": "Total comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r59", "r76", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r202" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Restricted deposit" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r68", "r122" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Stock Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r203" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate fluctuations on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": { "auth_ref": [ "r180" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.", "label": "Exercise of options granted to employees" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r52", "r53", "r54", "r78", "r79", "r80", "r82", "r87", "r89", "r92", "r121", "r149", "r151", "r181", "r182", "r183", "r188", "r189", "r197", "r204", "r205", "r206", "r207", "r208", "r209", "r250", "r251", "r252", "r281" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r145", "r146", "r147", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r166", "r200", "r220", "r221", "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r145", "r155", "r156", "r161", "r166", "r200", "r220" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r145", "r146", "r147", "r155", "r156", "r161", "r166", "r200", "r221" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r145", "r146", "r147", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r166", "r200", "r222" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r145", "r146", "r147", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r166", "r220", "r221", "r222" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "verboseLabel": "Derivatives" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnContractTermination": { "auth_ref": [ "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.", "label": "Gain (Loss) on Contract Termination" } } }, "localname": "GainLossOnContractTermination", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r60" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r58", "r76", "r102", "r104", "r107", "r110", "r112", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r202" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r67" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase in accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r67" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "(Increase) decrease in accounts receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r67" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Decrease in other receivables and prepaid expenses" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "auth_ref": [ "r256", "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For investments which are quantified by principal amount, the principle balance held at close of period.", "label": "Investment Owned, Balance, Principal Amount" } } }, "localname": "InvestmentOwnedBalancePrincipalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "verboseLabel": "Investment in marketable securities" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r36", "r76", "r106", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r192", "r194", "r195", "r202", "r214", "r215" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r76", "r120", "r202", "r216", "r234", "r243" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37", "r76", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r192", "r194", "r195", "r202", "r214", "r215", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r8", "r9", "r10", "r19", "r20", "r76", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r192", "r194", "r195", "r202", "r214", "r215" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Claim amount paid" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r129", "r130", "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Loss Contingency, Damages Sought, Value" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Gain (loss) on marketable securities" } } }, "localname": "MarketableSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Investment in marketable securities" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r65", "r66", "r69" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r47", "r49", "r54", "r55", "r69", "r76", "r81", "r83", "r84", "r85", "r86", "r88", "r89", "r90", "r102", "r104", "r107", "r110", "r112", "r120", "r133", "r134", "r135", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r198", "r202", "r236", "r246" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows", "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Financial income (expenses), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r102", "r104", "r107", "r110", "r112" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r212" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r212" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r211" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r68" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "General" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/General" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitmentsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the nature and terms of commitment.", "label": "Other Commitments, Description" } } }, "localname": "OtherCommitmentsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r42", "r44" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation differences" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r69" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Expense arising from restricted shares issued to compensate waiver by a shareholder" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r63" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Investment in right-of-use asset" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r62" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r171", "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r30", "r31" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Other receivables and prepaid expenses" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Net proceeds from from offering", "verboseLabel": "Proceeds from Issuance Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r64" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of shares, net of issuance costs", "verboseLabel": "Proceeds from common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r64" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r15", "r123", "r216", "r238", "r244" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r187", "r230", "r261" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development expense", "negatedLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r74", "r232", "r240" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r151", "r184", "r216", "r242", "r253", "r255" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r78", "r79", "r80", "r82", "r87", "r89", "r121", "r181", "r182", "r183", "r188", "r189", "r197", "r250", "r252" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r100", "r101", "r103", "r108", "r109", "r113", "r114", "r115", "r152", "r153", "r231" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule of Stock Based Expenses" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r162", "r163", "r164", "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfFairValueOfFinancialAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r170", "r177", "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair value of Financial Assets and Liabilities" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r171", "r179" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "negatedLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r67" ], "calculation": { "http://mysizeid.com/role/InterimStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation", "terseLabel": "Shares based compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows", "http://mysizeid.com/role/ScheduleOfStockBasedExpensesDetails", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares available for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of options expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r169", "r173" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Price per share", "verboseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r39", "r52", "r53", "r54", "r78", "r79", "r80", "r82", "r87", "r89", "r92", "r121", "r149", "r151", "r181", "r182", "r183", "r188", "r189", "r197", "r204", "r205", "r206", "r207", "r208", "r209", "r250", "r251", "r252", "r281" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r78", "r79", "r80", "r92", "r231" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r71", "r72", "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Restricted shares issued to shareholder" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r21", "r22", "r149", "r151" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Exercise of options granted to employees, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r149", "r151" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of shares, net of issuance cost of $1,000, shares", "terseLabel": "Stock issued during period, shares issue", "verboseLabel": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r149", "r151" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Restricted shares issued to shareholde, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r149", "r151", "r175" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r149", "r151" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of shares, net of issuance cost of $1,000" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r21", "r22", "r149", "r151" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Restricted shares issued to shareholder (*)" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r27", "r28", "r76", "r119", "r120", "r202", "r216" ], "calculation": { "http://mysizeid.com/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets", "http://mysizeid.com/role/InterimStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Capital -" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r210", "r218" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r210", "r218" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r210", "r218" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r210", "r218" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r217", "r219" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Events Subsequent to the balance sheet date" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDate" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/GeneralDetailsNarrative", "http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non cash activities:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/ContingenciesAndCommitmentsDetailsNarrative", "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r93", "r94", "r95", "r96", "r97", "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants and Rights Outstanding, Maturity Date", "verboseLabel": "Warrant expiring date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative", "http://mysizeid.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/EventsSubsequentToBalanceSheetDateDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Basic and diluted weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mysizeid.com/role/InterimStatementsOfComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r219": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r262": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r263": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r264": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r265": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r266": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r267": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r268": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r269": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r271": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r272": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r273": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r274": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r275": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r276": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r277": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r278": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r279": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" } }, "version": "2.1" } ZIP 43 0001493152-21-028645-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-028645-xbrl.zip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�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